Abstract
This article provides recommendations for implementing quantitative susceptibility mapping (QSM) for clinical brain research. It is a consensus of the International Society of Magnetic Resonance in Medicine Electro-Magnetic Tissue Properties Study Group. While QSM technical development continues to advance rapidly, the current QSM methods have been demonstrated to be repeatable and reproducible for generating quantitative tissue magnetic susceptibility maps in the brain. However, the many QSM approaches available have generated a need in the neuroimaging community for guidelines on implementation. This article outlines considerations and implementation recommendations for QSM data acquisition, processing, analysis, and publication. We recommend that data be acquired using a monopolar 3D multi-echo GRE sequence and that phase images be saved and exported in DICOM format and unwrapped using an exact unwrapping approach. Multi-echo images should be combined before background field removal, and a brain mask created using a brain extraction tool with the incorporation of phase-quality-based masking. Background fields within the brain mask should be removed using a technique based on SHARP or PDF, and the optimization approach to dipole inversion should be employed with a sparsity-based regularization. Susceptibility values should be measured relative to a specified reference, including the common reference region of the whole brain as a region of interest in the analysis. The minimum acquisition and processing details required when reporting QSM results are also provided. These recommendations should facilitate clinical QSM research and promote harmonized data acquisition, analysis, and reporting.
Keywords: Quantitative Susceptibility Mapping, ISMRM Study Group, Clinical Brain Research, Magnetic Resonance Imaging, Data Acquisition, Data Analysis
1. Introduction
Brain quantitative susceptibility mapping (QSM) is increasingly being used to identify calcifications and study the concentration of iron and myelin in tissue, oxygen consumption, as well as changes in these quantities associated with normal brain development, aging, and neurological diseases. These diseases include hemorrhagic stroke, multiple sclerosis (MS), Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and tumors 1–15. Particularly, QSM 1) enables differentiation between tissues that are paramagnetic (relative to water), including hemorrhages, and more diamagnetic than water, including calcifications 16–19, and their quantification with additional R2 or R2* mapping 1,20–29 and 2) improves anatomical visualization 30–32 and segmentation 33,34. The latter has proven valuable for presurgical mapping of deep gray nuclei targets in deep brain stimulation 30,35–39. QSM is also utilized to study imbalances in neurotransmitter levels or metabolism in psychiatric disorders such as psychosis 40,41 and depression 42,43, and to investigate neural mechanisms through which alcohol affects the brain 44–46. An important feature of QSM, when compared to, e.g., R1 or R2 relaxometry, is that its results may be more independent of field strength and scanner manufacturer when a consistent reconstruction QSM pipeline is used 47,48.
Nevertheless, there is currently no consensus or white paper on how to perform brain QSM in the clinical setting, despite extensive reviews on QSM techniques and applications 3,6,7,49–62 and strong QSM community interest in identifying the best algorithms 63–66. QSM is not yet a standard product on most MRI systems, although some scanner vendors are beginning to offer works-in-progress or even product software packages for QSM. However, there are growing demands for a robust “end-to-end” QSM recipe that covers acquisition, processing, and presentation in scientific publications, especially in the neuroimaging community. For example, this need was highlighted at the group discussion of the February 2022 workshop of the North American Imaging in MS Cooperative, as QSM is critical for depicting the paramagnetic rim of chronic active MS lesions 67–75. In response to this need, QSM investigators in the Electro-Magnetic Tissue Properties Study Group (EMTP SG) of the International Society of Magnetic Resonance in Medicine (ISMRM) established a QSM Consensus Committee to define a consensus approach and determine a series of recommendations.
This paper presents the consensus approach and specific recommendations for implementing QSM in clinical research. The consensus is intended as a guide for researchers with access to technical expertise in MRI acquisition and image processing. The main purpose is to facilitate the use of QSM in patient studies and clinical trials. Guidelines for clinical practice are beyond the current scope.
The QSM Consensus Committee is made up of QSM experts and a community of experienced QSM users and has prioritized its recommendations on 1) clinical applicability with robustness and simplicity, instead of state-of-the-art acquisitions and processing algorithms, 2) description clarity, emphasizing 3 tesla (T), the field strength most widely used in clinical brain research, with only general guidance for other field strengths (1.5T and 7T) where possible, and 3) implementation specificity, focusing on acquisition with multi-echo gradient-recalled echo (GRE), which is very sensitive to the field generated by tissue magnetization gained in MRI in proportion to magnetic susceptibility. Specific issues with no committee consensus (e.g., due to insufficient evidence) are indicated as such in the paper, and these recommendations may provide a starting point for application-specific improvements.
The remainder of this paper is organized into nine sections, covering data acquisition, image processing, image analysis, and presentation of QSM studies in scientific publications (Fig. 1). Data acquisition is split into two sections: Section 2) pulse sequences and protocols, and Section 3) coil combination, saving, and exporting. Image processing is split into four sections corresponding to four processing steps: Section 4) phase unwrapping and echo combination, Section 5) creation of masks, Section 6) background field removal, and Section 7) dipole inversion. Image analysis, Section 8, focuses on the analysis of susceptibility maps. The last section on presentation, Section 9, covers description in scientific publications. Section 10 provides a summary. Each section presents a general overview of the subject matter expounding the consensus approach, and the consensus statement specifying recommendations. Readers interested only in the consensus recommendations may skip the overview and proceed directly to the recommendation.
Figure 1:
The key elements of this consensus paper are described in Sections 2–9. The first two of these sections cover acquisition: 2) pulse sequences and protocol and 3) coil combination, saving, and exporting. The next four sections cover image processing: 4) phase unwrapping & echo combination, 5) creation of masks, 6) background field removal, and 7) dipole inversion. The last two sections cover analysis and presentation in scientific publications: 8) analysis of susceptibility maps, and 9) presentation and publication. The image output from each section is further detailed in the corresponding section.
This paper is accompanied by harmonized pulse sequence protocols for several major platforms (current software versions in 2022) and sample code to perform the recommended processing steps (Supporting Information: the Sepia toolbox 76, https://github.com/kschan0214/sepia). The contributions of the members of the QSM Consensus Committee are listed in Supporting Information I, Section S1.1, along with an overview of the history and approach of the initiative (Section S1.3). For many sections, expounded rationale and additional considerations are provided in Supporting Information IV. The version of this manuscript which was endorsed by the EMTP SG, in which additional considerations are integrated into the main text, is archived separately 77. The Acknowledgement section lists all individuals who contributed significantly to the consensus recommendations in verbal or written form.
2. Pulse Sequences and Protocol
This section describes recommendations to robustly acquire MRI data for QSM.
2.1. Overview
Most major MRI manufacturers, if not all of them, provide a radiofrequency (RF)-spoiled 3D multi-echo GRE pulse sequence from which one can obtain phase images for QSM in addition to the standard T2*-weighted magnitude images. The GRE sequence is probably the most elementary sequence in the MRI sequence tree, consisting in its simplest form of an RF excitation pulse followed by acquisition of a gradient recalled echo, which for the multi-echo variant is repeated at various echo times (TEs) before the next excitation pulse is applied. This sequence is often used for calibration steps, such as obtaining a field map for shimming. We recommend the following principles for designing a QSM acquisition protocol based on a RF- and gradient-spoiled 3D multi-echo GRE sequence:
Aim to set the longest TE (the TE of the last echo) equal to at least the T2* value of the tissue of interest. The first echo time (TE1) should be as short as possible and the spacing between echoes (ΔTE) should be uniform.
Use the minimum repetition time (TR) and set the flip angle to the Ernst angle ( for tissue in the target region.
While QSM can be achieved with one echo, two is the minimum number of echoes needed to separate the intrinsic transmit RF phase from the magnetic field-induced phase (see Section 3 below). Because phase SNR is maximal when TE = T2*, the use of multiple echoes ensures that high SNR field estimates are obtained for tissues with a range of T2* values. Acquisition of echoes with TEs extending well beyond the longest tissue T2* values is generally avoided as their phase and magnitude signals are often compromised by macroscopic field effects from nearby strong susceptibility sources (e.g., large veins).
Use the minimum readout bandwidth which generates acceptable distortions. At 3T, 220 Hz/pixel is often sufficient (two-pixel fat-water shift). Such acquisitions negate the need to use fat suppression for brain applications.
Use isotropic voxels of at most 1 mm to reduce partial volume-related estimation errors 78.
Use 3D acquisition instead of 2D acquisition to avoid potential slice-to-slice phase discontinuities in 2D phase maps 79.
Use a monopolar gradient readout (fly-back) to avoid geometric mismatch and eddy current-related phase problems between even and odd echoes in bipolar acquisitions 80.
Consider using flow compensation when targeting vessels, but note that flow compensation is often only available and effective for the first echo, while flow artifacts increase in later echoes 81. More detailed rationale and additional considerations are provided in Supporting Information IV.
2.2. Consensus Recommendations
The recommendations in this section are based on protocols currently available on commercial scanners which do not require a special research agreement with the scanner manufacturer:
-
2.a.
Use 3D multi-echo RF- and gradient-spoiled GRE with monopolar readout. Three or more echoes should be acquired and the TE range should include the T2* times of the target tissues.
-
2.b.
Use the minimum available TR (given selected TEs).
-
2.c.
Set the excitation flip angle to the Ernst angle for target tissues (e.g., white matter).
-
2.d.
Use whole brain coverage.
-
2.e.
Use isotropic resolution with a voxel edge length of at most 1 mm non-interpolated at 3T.
-
2.f.
Use accelerated imaging methods (e.g., parallel imaging or compressed sensing) available as product sequences.
-
2.g.
Use receive coil arrays with a large number of elements (preferably at least 12) covering the whole brain.
Acquisitions for QSM reconstructions can be performed at all clinical field strengths using the protocol recommendations provided here, but higher field strengths provide several benefits. Both intrinsic SNR and susceptibility contrast increase with the static magnetic field, leading to higher CNR, and acquisition can be more time efficient at higher fields due to the shorter T2*. The recommended protocols implicitly integrate a compensation for lower SNR at lower through reduced spatial resolution, while keeping the total acquisition times similar. While useful data can be obtained at all field strengths, finer anatomical details in certain applications, such as lesions in multiple sclerosis 82, might be difficult to visualize at 1.5T.
Supporting Information I, Section S1.4 contains sample protocols for 1.5T, 3T, and 7T.
3. Coil Combination, Saving, and Exporting
This section recommends effective and practical solutions for generating phase images that can be used for QSM and provides guidance on how to save and convert the format of the phase images in preparation for QSM analysis.
3.1. Overview
Modern MRI systems use phased array coils made up typically of 12, 32 or 64 elements, which provide higher SNR than a single birdcage coil and facilitate parallel imaging 83–85. However, the images from individual coil elements are sensitive to only a part of the FOV and need to be combined to generate a single image with high SNR throughout the brain, a process that requires consideration of the differences between the coil signals.
Neglecting phase wraps (see Section 4), the phase measured with a particular RF coil element c in a GRE sequence, can be approximated by: . The first part, , is the phase shift caused by the deviation of the magnetic field from the uniform main magnetic field, . Neglecting second-order non-linear effects86, evolves linearly over time and is the term relevant for QSM. The second part, , is the phase at TE=0, known as the phase offset (or initial phase) of coil element . This contribution comprises effects that are common to all the RF receive coils, such as the phase of the transmit RF field , the effects of tissue conductivity 87, gradient delays and eddy current effects, and contributions that are unique to each receive coil, such as the coil sensitivity. Coil-dependent phase offsets must be removed prior to a complex summation of the coil signals, as shown in Figure 2, to avoid destructive interference. Destructive interference leads to reduced SNR and unphysical phase wraps in regions of the image, which cause artifacts in QSM 88. Complete destructive interference is often associated with phase wraps referred to as “open-ended fringe lines,” “phase singularities” or “cusp artifacts” (see Figure 3, left). These ill-behaved wraps cannot be fully removed by unwrapping (see Section 4).
Figure 2:
Steps in coil combination, saving, and exporting (illustrated for eight example coils from a 64-channel array and one echo). Each of the coils generates a phase image (left), which is modified by the coil sensitivity and other terms which make up the initial phase. The initial phase is removed (center left) using methods detailed in the text and referenced publications after which phase images are combined in the manufacturer’s reconstruction and saved for export in DICOM format (center right, with multiple echoes illustrated). QSM analysis software may require the DICOM data to be converted, offline, to NIfTI format (right). Images shown were acquired at 3T (Siemens Healthineers, Erlangen, Germany; Prisma Fit, VE11C) with a head/neck 64 channel coil and the recommended multi-echo GRE sequence (TE1=5.25ms; echo spacing=5.83ms; 5 echoes) using monopolar readout. The imaging data and a description of the acquisition and analysis protocols can be found in Supporting Information II.
Figure 3:
Some scanner manufacturers’ options for processing and saving phase images (like “Sum of Squares”) do not remove coil sensitivities. This becomes apparent in the combined phase images having open-ended fringe lines (left). Wraps in phase images generated using the recommended methods are quite symmetric across the brain mid-line (right), and (like contours on a topographic map) either begin and end at the edge of the brain tissues, or form closed loops within the brain.
All major 3T MR system vendors have effective solutions for generating phase images from RF array coils on their current software platforms. Most of these remove individual coil sensitivities, which are estimated by referencing to a coil with a relatively homogenous sensitivity over the object (usually the body coil). The reference data is acquired in a separate, fast, automated measurement, and the coil sensitivity correction is carried out on complex data either in k-space 83 or image space 89 before extraction of the phase. We recommend using the available ‘on-console’ vendor solutions listed in Section 3.2 and provide alternatives for older scanners and high field (≥ 7T).
Phase and magnitude images should be exported in DICOM format. However, most QSM tools require data to be in NIfTI format, and a number of tools are available to perform the necessary conversion. We recommend DCM2NIIX 90 (https://github.com/rordenlab/dcm2niix), which is a well-maintained open-source software with compiled versions for all major operating systems. Generally, phase changes related to positive susceptibility sources (those which are paramagnetic relative to water) are defined as being positive, but the possibility exists that vendors may use the opposite sign convention,91 in which case the sign of all phase values should be reversed.
3.2. Consensus Recommendations
We recommend the following manufacturers’ methods for combining phase images from array coils and saving phase data, listing the software versions for which these solutions have been tested and whether a research agreement is required. Detailed step-by-step descriptions and solutions for higher field scanners and older systems are provided in Supporting Information III.
-
3.aThe recommended solutions for saving phase images are, for
- Canon: SPEEDER, a version of SENSE which is available from MPower version 2.3 onwards and allows phase images to be reconstructed through a vendor-provided service password.
- GE: ASSET, a SENSE-similar solution which reconstructs magnitude, phase, real, and imaginary images without a research key on platforms MR30 onwards.
- Philips: SENSE, which provides well-combined phase images 84 without the need for a research key from software version 5 onwards.
- Siemens: “Adaptive-combined with prescan normalize” 92, which is available from software version VE11 onwards in the product GRE sequence.
- United Imaging: an inter-coil referencing and weighted correction approach which is available from software version v9 onwards without the need for a research key.
-
3.b
Exporting data: Data should be exported in (classic) DICOM format.
-
3.c
Format conversion: if the analysis pipeline requires NIfTI data, DICOM data should be converted to NIfTI using DCM2NIIX.
4. Phase Unwrapping and Echo Combination
This section describes the methods used to resolve phase aliasing and calculate a field map from multi-echo GRE data.
4.1. Overview
MRI phase measurements are constrained to an interval of radians and are, therefore, subject to phase wraps or phase aliasing artifacts, i.e., the measured phase modulo . Such phase wraps introduce a phase difference of an integer multiple of between the measured phase, and the true phase . Phase wraps are usually visible as discontinuous phase jumps in the phase images (Figs. 3 and 4). To a first-order approximation, , where is the proton gyromagnetic ratio in rad/T/s. To obtain an accurate estimate of the field shift, for QSM, both phase wraps and the phase offset need to be removed from the measured phase, 56.
Figure 4.
A) Example wrapped phase images at different echo times after proper coil combination (same images as shown on the right-hand side of Figure 2). More phase wraps are observed at later echoes (bottom). B) Example unwrapped phase images (using ROMEO template phase unwrapping with MCPC3D-S phase offset correction). C) Frequency map of the total field estimation, i.e., in the unit of Hz, after echo combination using weighted echo averaging.
Over the years, different phase unwrapping methods have been adapted, refined and applied to MR phase imaging; including time-domain unwrapping methods (with multi-echo acquisition) such as CAMPUS 93 and UMPIRE 94, and spatial-domain unwrapping methods such as region-based PRELUDE 95 and SEGUE 96, path-based PHUN 97, SPUN 98, BEST-PATH 99 and ROMEO 100, and Laplacian unwrapping 101. The Laplacian unwrapping method is robust and gives wrap-free phase results even under low SNR conditions, but can result in high-frequency errors that propagate into susceptibility maps102. It is also noted that Laplacian unwrapping only gives an approximation of the underlying unwrapped phase, especially when using the commonly used Fourier-based implementation, while region-based and path-based unwrapping give quantitatively more accurate estimates of the unwrapped phase 56,100. Region-based and path-based methods are termed “exact unwrapping methods” below 100. When comparing exact unwrapping methods to Laplacian unwrapping, unwrapping errors (e.g., in veins and hemorrhages) are observed to be smaller in the former, improving QSM quantification accuracy, e.g., for oxygenation estimation 103,104.
Multi-echo phase images can be combined to achieve a more accurate estimate of the underlying field shift, than can be obtained from single-echo phase images 105. This is because combining multi-echo phase images can remove the phase offset contribution and give higher SNR in the estimated tissue field and susceptibility maps (Fig. 4). The optimum approach may depend on the application, but two echo combination methods have been widely used for QSM – nonlinear complex data fitting 106 and weighted echo averaging 107.
The nonlinear complex data fitting approach takes into account the Gaussian noise in the complex images 106 and estimates the field shift, and phase offset, together as parameters from fitting the complex MR signal over echo time, with the requirement of having acquired three or more echoes 106. This approach usually needs spatial phase unwrapping to be performed after the fitting, e.g., on a phase estimate proportional to the fitted field shift, with being the echo spacing, wrapped again between and . Nonlinear complex data fitting is more robust than linear phase fitting for guarding against phase noise or phase errors due to partial volume effect and intra-voxel phase aliasing at long TEs and around large susceptibility sources, e.g., veins and hemorrhages.
If echoes are acquired over a useful range of TE values (depending on T2* values of the tissues of interest, see Section 2), the weighted echo averaging approach gives higher SNR for estimating the field shift, than the complex data fitting approach107–109. Unlike nonlinear complex data fitting, this approach needs the phase data at each TE to be spatially unwrapped first. It also requires explicit removal of the phase offset through subtraction of the estimated phase offset (by extrapolating the linear phase evolution to zero echo time) 110 from the phase measured at each TE. Unwrapping errors at longer TEs in voxels with large field shifts and more pronounced noise can be reduced by the “template” unwrapping approach used in ROMEO, which performs path-based spatial unwrapping on an early echo and unwraps other echoes on the basis of an expected linear phase evolution 100. This, combined with weighted echo averaging, reduces the effect of such errors in the estimated field map.
4.2. Consensus Recommendations
-
4.a.
Use an exact phase unwrapping method.
-
4.b.
Perform echo combination before background field removal.
-
4.c.
The optimal pipeline for phase unwrapping and echo combination depends on the acquisition and application. In most situations, to achieve better SNR, we recommend using weighted echo averaging after template phase unwrapping and explicit phase offset removal. When phase errors persist due to pathology with strong susceptibility sources, we recommend nonlinear complex data fitting followed by spatial phase unwrapping.
5. Creation of masks
This section provides recommendations on creating masks for background field removal (Section 6), dipole inversion (Section 7), and visualization (Section 9).
5.1. Overview
Masking is often overlooked when describing a QSM pipeline, but is a crucial step 111, particularly for background field removal (see Section 6). Masking refers to selecting a region of interest (ROI) within the whole field of view and applying a process or function only within this ROI. In QSM, field maps, , are masked primarily because most background field removal algorithms require a mask. By design, background field removal eliminates all sources of magnetic susceptibility outside of the mask, leaving only the local magnetization within the mask. In general, masks should cover the largest ROI possible to prevent exclusion of brain tissue with a sufficient signal-to-noise ratio to have reliable phase/field values.
Masks may be created by using heuristic thresholding operations on available subject images, including magnitude images, T2* maps, quality maps, or SNR maps. In addition, segmentation algorithms may be based on pre-learned shapes or on the optimization of functionals 112–118. In particular, the Brain Extraction Tool (BET) 119 from the FMRIB Software Library (FSL) is a widely-used method for brain masking (skull stripping), although it may fail when pathologies or injuries are present 120,121. BET is a magnitude-image based algorithm that effectively removes non-brain tissues, air, and bone from magnitude images of the head. Using the last-echo magnitude image for BET masking is a robust way to remove regions with signal dropout. 122 However, this is undesirable if such regions are of interest, e.g., the cortex right under the skull, which may be compromised or removed with this approach, and thus this approach is not usually recommended. A more balanced approach is to use magnitude images combined across TEs (e.g., using sum of squares or weighted averaging), although using the first-echo magnitude is a good alternative for just the deskulling action. Alternatives to BET include standard template-based brain-extraction 123. Deep learning-based segmentation, a rapidly developing field 124–127, may also be considered.
QSM is also vulnerable to errors and artifacts arising from unreliable phase data that may not be directly reflected in the corresponding magnitude data. These may be caused by coil combination errors, flow in vessels, and other factors. For this reason, it has been proposed to use phase-based quality maps in addition to magnitude-based de-skulling (i.e, BET masking using the first echo) to achieve a more reliable brain mask 122. A straightforward method to obtain a phase quality map is to threshold the inverse of the noise map provided by the complex nonlinear multi-echo fitting algorithm (described in Section 4) at its mean value 106,122. This thresholding maintains an adequate number of voxels, as it is applied to the entire field of view (FOV), and the distribution of values exhibits bimodal characteristics. This approach effectively distinguishes between reliable and unreliable voxels, serving as a suitable initial approximation. However, modifying the threshold factor (e.g., by increasing its value by 20%) may improve results. To fine-tune the threshold value, it may be needed to inspect both the background field removal and dipole inversion results, as these will more easily reveal noisy voxels and artifacts arising from unmasked unreliable regions. Some exact phase unwrapping algorithms also provide phase-based quality maps 100,128, which can again be thresholded to identify voxels within the brain with unreliable phase values, and to provide a better estimation of the brain boundary 111,122,129.
Masking imperfections may result in small exclusion areas (“holes”) in the region of interest that need special attention. It is important to fill all holes, as the background field removal algorithms will suppress any susceptibility sources within these holes. This may lead to the inadvertent removal of pathologies and other clinically-relevant information. These holes can be reintroduced at the dipole inversion step to prevent streaking artifacts. Please refer to the Additional Considerations section for more details on this subject.
Finally, although some recent deep learning-based single-step QSM approaches have shown that explicit masking can be avoided 130–134, these methods require further study and validation to be considered for clinical applications and are therefore not included in the recommendations in this manuscript.
5.2. Consensus Recommendations
The recommendations below are summarized in Figure 5, and differences between masks (Masks 1–4 in Fig. 5) are highlighted in Figure 6.
Figure 5:
Block diagram of the masking stages. 1) Create an initial mask using FSL BET (Mask 1). 2) Threshold a phase-based quality map to create a mask of reliable phase values (Mask 2). 3) Multiply Mask 1 with Mask 2 and fill in holes for background field removal. 4) Erode by one or two voxels according to the output of the background field removal algorithm (and, optionally, reintroduce holes) for dipole inversion. Use Mask 4 without holes filled in for display and reporting susceptibility values. The magnitude and phase images shown are the same as those in Figure 4.
Figure 6:
Differences between masks in Figure 5. By using the reliable phase (Mask 2), the initial BET mask (Mask 1) can be further improved by removing unreliable phase data near the boundary (red). Mask 3 is used for background field removal. After removal, Mask 3 may need to be further eroded depending on the output of the background field removal algorithms (eroded region shown in blue). This is used for visualization of the results and reporting. Unreliable phase data inside the brain can also be masked out for dipole inversion (holes in green, with the final Mask 4 used for dipole inversion in white).
-
5.a.
Create an initial brain mask (Mask 1) by applying a whole-brain segmentation tool (such as BET) to either the combined (sum of squares) or the first echo magnitude image. The goal of this initial mask is to remove air, skull and other tissues, while preserving cortical areas. Further refinement is performed in the following steps.
-
5.b.
Create a mask of reliable phase values (Mask 2) by thresholding the phase quality map generated by the multi-echo combination method in Section 4. Multiply Mask 1 by Mask 2.
-
5.c.
After multiplication, holes should be filled to obtain the input mask for background field removal algorithms (Mask 3).
-
5.d.
If the background field removal method produces a smaller mask, as the reliable ROI, use this for dipole inversion (Mask 4). To avoid streaking artifacts from unreliable phase data within the brain, holes from Mask 2 can be reintroduced (i.e., multiply Mask 4 by Mask 2). For increased accuracy of susceptibility values inside pathological regions of low signal, e.g., hemorrhages and calcifications, mixing data from reconstructions with and without the holes can be performed.
-
5.e.
The calculated susceptibility map should be multiplied by the mask used for background field removal (without holes; Mask 3) before display, reporting of susceptibility values, or further analysis. While small holes can be ignored, since their values are extrapolated from neighboring voxels, large holes should be masked out or flagged (e.g., using NaN).
6. Background Field Removal
This section provides recommendations for the background field removal step.
6.1. Overview
In QSM, the background field is defined as the field generated by susceptibility sources outside the brain 57, while the field generated by brain sources is the tissue field (often called the local field). The total field map is the sum of these two fields. The susceptibility difference between brain tissue and one such source, air, is approximately 9 ppm 135, which is almost two orders of magnitude larger than the naturally occurring brain tissue susceptibility differences. Therefore, background fields can be significantly larger than the tissue field. However, pathologies such as hemorrhages can create a tissue field that is similar in magnitude to the background fields. Removal of the background field from the total field map, , allows the inversion to focus on the effects of spatial susceptibility variations in the brain (Figure 7). When background fields are not completely removed from , most dipole inversion methods will result in shadowing artifacts and/or experience a slow convergence rate.
Figure 7.
Process of background field removal estimates the background field component of the total field (first row; same images as shown on the right-hand side of Figure 4; unit is Hz) relative to a chosen region of interest (brain mask, third row) and subtracts it from the total field, resulting in the tissue field (fourth row; unit is Hz). The tissue field encodes the spatially varying susceptibility within the brain but is much smaller than the background field. This is illustrated by showing cross-sections (indicated by the dotted lines in the field images) in the total field (second row) and the tissue field (last row). The background field was calculated using the V-SHARP method.
Because the background field is spatially smooth, high-pass filtering has been a popular method to suppress it. However, high-pass filtering also removes the low spatial frequency components of the tissue field, leading to reduced accuracy in QSM. Methods that are based on the fact that background fields are harmonic functions have replaced heuristic filtering methods 57. Harmonic functions satisfy the Laplace equation within the brain and are completely determined by their values at the brain boundary 57,136.
The SHARP (Sophisticated Harmonic Artifact Reduction for Phase data) method, 137 and variants thereof use the spherical mean value property of harmonic functions. This property states that the average of a harmonic function over a sphere with arbitrary radius centered at any location but still contained within the brain is equal to the value of the harmonic function at that location. In practice, the need for a radius that is several voxels wide to overcome discretization effects leads to an erosion of the brain mask in which the tissue field can be computed. The most common variant of this method is V-SHARP 138, which involves multiple partial applications of SHARP with different radii to mitigate this erosion. E-SHARP 139 and other variants of SHARP 140,141 overcome the remaining erosion of one voxel required for V-SHARP. Other variants like HARPERELLA 142 combine SHARP with phase unwrapping. In general, SHARP-based methods perform less well at the boundary of the region of interest 57 and perform implicit low pass filtering due to the regularized deconvolution inherent in SHARP143.
The PDF (Projection onto Dipole Fields) method 144,145 finds a susceptibility distribution outside the brain that mimics the field inside that region. The field generated by those outside sources are approximately orthogonal to those generated by local sources, allowing background field removal to be formulated as a weighted linear least squares problem. Because the orthogonality breaks down at the boundary of the brain, like SHARP, this method performs less well at the boundary 57,144.
The LBV (Laplacian Boundary Value) method 136 assumes that the field at the boundary of the brain is entirely background field and finds a harmonic function that satisfies this boundary condition 136. While LBV can perform better than PDF and SHARP in some situations57, its performance has been observed to be highly dependent on the mask and on the quality of the field estimates at the mask boundary 146.
6.2. Consensus Recommendations
-
6.a.
Use V-SHARP to achieve good results in many situations, as it is less sensitive to imperfections in brain masking. This comes at a cost of a one-voxel erosion of the brain mask used for dipole inversion (Mask 4 in Fig. 5) at the brain surface and reduced accuracy at the edge of the brain.
-
6.b.
When whole brain mapping (including the cortex or veins near the brain’s surface) is desired, use PDF. This method will be slightly more accurate throughout the brain. PDF requires a good brain mask.
-
6.c.
Depending on the application, tissue field quality, i.e., the phase SNR especially near the boundary, must be balanced against mask erosion.
7. Dipole Inversion
This section provides recommendations for the field-to-susceptibility inversion step (Fig. 8): the inversion input is the tissue field, (with background fields removed; see previous section), and output is tissue magnetic susceptibility (relative to a reference value 147,148, see Section 8).
Figure 8.
The process of dipole field inversion starts from the tissue field (first row, same images as shown in the bottom row of Figure 7; unit is Hz) and estimates the susceptibility map (second row; unit is ppm).
7.1. Overview
The tissue field at a specific location is a summation of weighted contributions from all surrounding magnetic susceptibility sources, therefore a nonlocal quantity. Mathematically, 149–152 this summation is a spatial convolution () of the susceptibility with the unit dipole kernel :
| [1] |
Spatial deconvolution with the dipole kernel is needed to determine the local tissue susceptibility from the tissue field However, the dipole kernel value is zero at the cone surface of the magic angle (54.70) relative to the main field and very small close to it, making this deconvolution a poorly conditioned inverse problem 152–156. The measured tissue field contains deviations from perfect dipole patterns, particularly in regions with low signal-to-noise ratio (SNR). While the regions with large deviations are usually eliminated through masking (see Section 5 above), remaining deviations cause deconvolution errors in the calculated susceptibility, manifesting as streaking and shadowing artifacts 55,157.
Additional information about the susceptibility map can be incorporated through regularization, which helps to reduce streaking and shadowing artifacts in the solution 18,61,109,138,153,158–162. An optimization approach for incorporating this additional information is Bayesian inference, which can be formulated as the following minimization problem:
| [2] |
Here the first term is the data fidelity term, which approximates the noise in the field as Gaussian with weighting ; the second term is regularization with strength 109,159. The minimization problem is iteratively solved with the number of iterations determined by the desired convergence. The regularization strength depends on anatomy, susceptibility contrast, and SNR, and should be optimized to balance artifact suppression and image sharpness in each imaging protocol and application, using, e.g., the L-curve method 163,164, the measurement of image feature sharpness, 165 or radiological image scoring.
Various regularization strategies have been developed for QSM 18,55,63,102,109,138,153,156,158,159,161–163,166–173, as implemented in QSM software packages including FAst Nonlinear Susceptibility Inversion (FANSI) 161 (https://gitlab.com/cmilovic/FANSI-toolbox), Morphology Enabled Dipole Inversion (MEDI) 163,174 (http://pre.weill.cornell.edu/mri/pages/qsm.html), and STI Suite 175 (https://people.eecs.berkeley.edu/~chunlei.liu/software.html). Sparsity regularization is used in the openly accessible source codes for FANSI and MEDI; total variation (TV) as a specific sparsity regularization performed favorably in the two QSM reconstruction challenges 63,66. Zero-referencing to the cerebrospinal fluid (CSF) may be included as an extra regularization, which provides the CSF-uniformity and associated reduction of streaking and shadowing artifacts, 147,176 see further discussion in the next section.
QSM can be improved using 1) nonlinear forward signal modeling, particularly in tissue of large susceptibility values, such as hemorrhages or calcifications 63,66, and 2) deep learning-based reconstruction 54,132,177,178, which may require careful management of generalization issues related to limited training data 63,66.
Streaking artifacts may arise from strong susceptibility sources near borders and within the brain, where the Gaussian noise model breaks down and field estimation becomes erroneous 106. These artifacts may be suppressed by masking out or reducing the weight of less trustworthy voxels 106, improving the brain mask 111,179,180, preconditioning 181,182, and using in-painting techniques such as MERIT 106 and L1 data fidelity 183.
Shadowing artifacts may arise from residual background fields. This shadowing may be reduced by improving background field removal such as harmonic incompatibility removal 102,184 and by suppressing slowly-varying spatial frequency components through regularization 185 or preconditioning 55,181.
Some algorithms do not incorporate spatial constraints for suppressing streaking and shadowing artifacts but explicitly modify the dipole kernel instead 55,157, for example, thresholded k-space division 145,156,169,186–188. Implicit regularizations based on the number of iterations may work, but these methods have limited denoising capabilities and may be less robust than the sparsity regularization optimization approach 61,168,189.
The above-mentioned QSM reconstruction challenges 63,66 include publicly available data that can be used to ensure that custom pipelines achieve results similar to the methods recommended in this consensus.
7.2. Consensus Recommendations
-
7.a.
Use an optimization approach for dipole inversion with a sparsity-type regularization that is commonly used in compressed sensing 55. Specific sparsity types include L1-norm, total variation, and generalized total variation, which likely provide similar outcomes. Further algorithm developments and evaluations are needed to provide a more specific consensus on the sparsity type.
-
7.b.
Use the default sparsity type, regularization strength and number of iterations in a QSM software package, such as the processing pipelines recommended here (Supporting Information II), including FANSI, STI Suite, and MEDI, where these default parameters have been optimized for common brain protocols. If the acquisition protocol recommended here (Supporting Information I, Section S1.4) is substantially altered, researchers should perform an L-curve optimization or other method on at least one typical case with the specific study protocol to fine tune the regularization strength and number of iterations and then fix these parameters for the same protocol.
8. Analysis of Susceptibility Maps
This section provides recommendations for quality control, referencing of susceptibility maps, and the quantification of susceptibility values for clinical research, e.g., when performing group studies. Possible tools for susceptibility quantification are provided in Supporting Information I, Section S1.5. Figure 9 summarizes the recommendations of this section.
Figure 9:
Schematic for susceptibility map analysis in case of a study interested in susceptibility values of the putamen (blue ROI on the susceptibility map, ) and globus pallidus (red ROI). Data with streaking artifacts that affect the ROIs need to be excluded (or recalculated when applicable to all study data). ROI generation benefits from the inclusion of susceptibility contrast, e.g., by calculation of hybrid images (blue) or use of T1-weighted and susceptibility data (green). Susceptibility maps need to be referenced, then regional average susceptibility values () can be computed from referenced susceptibility maps (). The shown susceptibility map without artifacts is the same as the one in Figure 8.
8.1. Overview
8.1.1. Quality control
Only a few tools exist that allow fully automatic QSM calculation and evaluation directly from scanner DICOM data, with all the steps outlined in Sections 2 to 8111,190. Most QSM applications still require multiple processing steps, which can result in error amplification/propagation or inconsistencies between steps, rendering QSM workflows prone to i) reconstruction artifacts (Table 1) and ii) errors in measurement of region-specific susceptibility values. Particularly, the use of one or several masks to exclude unreliable phase data and for background field removal can result in missing areas in computed susceptibility maps. When voxels in those regions are not properly excluded in subsequent analyses, regional mean values may be biased by these erroneously included zero-valued voxels. This can be resolved by incorporating the eroded background-correction mask (Mask 4 without holes in Fig. 5) in the ROI masks. Deviation from radiological orientation (right-left flip) in the final susceptibility maps can be another potential issue arising from the combination of toolboxes. These flips can be revealed easily by comparing brain features between QSM and the original GRE magnitude images on the scanner console.
Table 1.
Reconstruction artifacts, their possible sources, and strategies to identify, mitigate these artifacts and criteria for excluding data.
| Artifact | Streaking and shadowing artifacts
|
Incorrect susceptibility values
|
(Regional) strong noise
|
|---|---|---|---|
|
Typical sources |
- large susceptibility differences (air-tissue, calcification, hemorrhage etc.) - poor brain mask - use of late TEs and dynamic field fluctuations (especially at higher field strength) in combination with unsuitable mask - inversion algorithm unsuitable for the data (e.g. presence of strong susceptibility sources) - poor choice of reconstruction parameters (for phase unwrapping, background field removal or inversion algorithm) - incorrect coil combination |
- Mismatch between acquired and assumed TE values during the reconstruction, e.g., due to unanticipated acquisition protocol changes | - incorrect coil combination - suboptimal image acquisition (coverage, 2D) |
|
Identification |
- manual/visual quality control - automatic detection of outlier regions on phase images or QSM 190 (beware of outliers due to pathology) - automated histogram analysis - use of image quality measures such as the structural similarity index - manual/visual quality control |
- outlier detection (based on mean/median ROI values) | (see streaking and shadowing artifacts) |
|
Mitigation |
- adjust masking, reconstruction algorithm and parameters (e.g., exclude late TEs from echo combination) - use appropriate coil combination |
- verification of imaging parameters from DICOM header (manually or automatic) - pull imaging parameters from data instead of hard coding it in the pipeline |
- use appropriate coil combination - use of recommended acquisition protocol |
|
Data exclusion |
- exclude if ROI affected and recalculation of the entire study cohort with the adjusted pipeline not possible (to avoid bias) | - exclude if recalculation of the entire study cohort with the corrected pipeline not possible (to avoid bias) | - exclude if recalculation of the entire study cohort with the adjusted pipeline not possible (to avoid bias) |
8.1.2. Referencing and choice of reference region
QSM can only assess relative susceptibility differences between tissues, as phase data reflect field distortions caused by spatial susceptibility differences58,148. To obtain susceptibility values that are comparable between repeated measurements, subjects, and scanners, consistent referencing of susceptibility maps is required. In QSM, internal reference regions are used, and external reference regions generally are not. The ideal choice of a reference region for brain QSM is still under debate148. Different regions used in the literature come with certain advantages and disadvantages and will lead to different susceptibility values in the resulting susceptibility map.
In the case of widespread pathology such as in multiple sclerosis or Alzheimer’s disease, there might not be an ideal choice of reference region. Large reference regions are generally advantageous over small regions, which are more affected by potential local lesions, reconstruction inhomogeneities and other artifacts (less averaging), which are then propagated to all other regions in the map by the referencing process. This issue reduces statistical power and therefore 3D segmentation of reference regions is advisable to include a greater number of voxels. Consequently, whole-brain referencing (using the largest possible mask) is considered stable and reproducible.
The dependence of white matter apparent susceptibility on the fiber orientation with respect to the main magnetic field191–195 can be a source of additional variability when using a reference that includes white matter regions. In the case of widespread pathology, where no ideal reference region exists, two reference regions could be used to evaluate whether the choice of reference region affects results. If both choices reveal the same significant findings, these can be assumed with greater confidence to originate from the presence of pathology, instead of being an artifact from susceptibility referencing196.
For local pathology, the use of contralateral or surrounding tissues as a reference is an effective strategy to avoid introducing artificial susceptibility differences.
Table 2 lists advantages and disadvantages of common reference regions. More details on referencing can be found in dedicated literature147,148.
Table 2.
Commonly used reference regions in the literature.
| Reference region | advantages | disadvantages |
|---|---|---|
| cerebrospinal fluid 147,168,216–221 | · automatic pipelines available 147 · no orientation dependence · susceptibility of CSF unlikely to be significantly affected by disease |
· ventricles can be small in young subjects, resulting in segmentation inaccuracies · partial volume effect because of possibly small ventricles in young subjects or compression of ventricles by pathology · CSF flow artifacts · choroid plexus can affect CSF susceptibility assessment in lateral ventricles |
| global white matter regions (not restricted to internal capsule) 31,222,223 | · large region | · orientation dependence · might be affected by pathology, e.g. demyelination, gliosis, hemorrhage, atrophy |
| internal capsule 23,224–226 | · orientation dependence · might be affected by pathology, e.g. demyelination, gliosis, hemorrhage, atrophy, focal lesions · Relatively small region |
|
| whole brain 196,202,202,227 | · no extra mask required, brain mask from previous processing steps can be used · intrinsic for some methods · large region |
· might be affected by pathology and age (e.g. myelination, global demyelination, gliosis, iron accumulation, hemorrhage) · due to large WM fraction similar limitations as “white matter” above. |
8.1.3. Effect of segmentation on susceptibility quantification (iron, white matter changes, lesions, vessels, oxygenation)
An accurate segmentation of ROIs is essential to uncover subtle changes in regional susceptibility values that might indicate pathology, or to establish normative values. Many available automated neuroimaging segmentation tools are optimized for use with T1-weighted images or require T1-weighted input data197. However, when using these methods for the analysis of susceptibility maps, the segmentation and registration accuracy in many structures of interest (e.g., basal ganglia) can depend on T1 contrast198, which is also affected by tissue iron199,200, and the generally low visibility of some deep gray matter regions on T1-weighted images201. Previously, it has been shown that the use of a QSM or hybrid QSM-T1-weighted contrasts for template generation improves atlas and voxel-based analyses33,34. Consequently, methods that rely solely on T1-weighted contrast may be biased and suffer from inaccuracies33,34. Therefore, using multi-contrast segmentation can be considered the best approach to avoid template bias202. Furthermore, partial volume effects could be corrected by eroding of ROIs81, only using high susceptibility voxels (in case of positive susceptibility)203, or using a “partial volume map” for correction204.
8.2. Consensus Recommendations
-
8.a.
When ROIs are affected by artifacts, exclude data by automated detection of outliers or outlier regions, use of image quality measures or visual inspection.
-
8.b.
Ensure that analysis methods do not include voxels of the susceptibility map with unreliable values, e.g., those that lie outside of the eroded background field removal mask.
-
8.c.
Always reference susceptibility maps to an internal reference region before performing further analyses.
-
8.d.
When choosing a reference region, consider the study design, influence and possible bias of pathology, and discuss accordingly. For widespread pathology, cross-checking results using two different reference regions can be considered a safe means to exclude bias.
-
8.e.
Segment reference regions in 3D.
-
8.f.
Always include commonly-used reference regions in the analysis and report mean and standard deviation in these regions.
-
8.g.
Consider incorporating QSM contrast in ROI segmentation or ensure that T1w-based methods are accurate.
9. Presentation and Publication
The purpose of the recommendations in this section is to facilitate the interpretation and replicability of future findings with QSM, future meta-analyses, and the comparison among studies by recommending how findings should be presented.
9.1. Overview
The general recommendation is to report as much information as possible regarding data acquisition (hardware and scan parameters), reconstruction pipeline, analysis procedure and results. Among the information entities relevant for QSM, the Consensus Organization Committee identified those that should always be reported in any manuscript, and assigned a “traffic light ranking” (green, orange, red) to items that were not considered essential, as described in Section 9.3.1, to help identify the information that should be prioritized when space is limited. The last part of this section reviews important aspects, potential limitations and confounds that should be considered when presenting QSM findings in scientific papers.
9.1.1. Acquisition and reconstruction pipeline
Ideally, the acquisition hardware should be described in a single sentence reporting the scanner field strength, model, vendor, software release version, and type of coil used (including the number of channels). The QSM Consensus Organization Committee considered it as essential to indicate acquisition sequence type and several acquisition parameters including the number of echoes, TEs, TR, flip angle, bandwidth, resolution and scan duration.
It is considered essential to describe the toolbox and reconstruction pipeline, and list the algorithms used. The numerical values of parameters used should be listed, even if they were the default parameters.
Tables 3, 4 and 5 provide an overview of recommendations pertaining to the description of acquisition hardware, sequence type/parameters, and reconstruction/analysis pipelines, respectively. A representative paragraph presenting this information in a scientific paper is provided in Supporting Information IV, Section 9.3.2.
Table 3.
Recommendations for reporting of parameters of the acquisition hardware. The reporting of specific items is considered essential if there was unanimous consensus in reporting them. Items that were not considered essential were assigned a “traffic light ranking” (green, orange, red; detailed in Supporting Information IV, Section 9.3.1): it is recommended that items with a green or orange flag are reported.
| Item | Notes and examples | Recommended |
|---|---|---|
| Field strength | DICOM tag (0018,0087) | essential |
| Vendor | DICOM tag (0008, 0070) | essential |
| Scanner model | DICOM tag (0008, 1090) |
|
| Software release | DICOM tag (0018, 1020) |
|
| Type of coil(s) used, including information on number of channels | e.g. “... a transmitting body-coil and a 64-channel head-and-neck receiving coil” |
|
| Gradient system | e.g. “... a gradient system with maximum amplitude = 50 mT/m and slew rate = 200 mT/m/ms” |
|
Table 4.
Recommendations for reporting of parameters of the acquisition sequence. The reporting of specific items is considered essential if there was unanimous consensus in reporting them. Items that were not considered essential were assigned a “traffic light ranking” (green, orange, red; detailed in Supporting Information IV, Section 9.3.1): it is recommended that items with a green or orange flag are reported.
| Item | Notes | Recommended |
|---|---|---|
| Acquisition sequence type | 2D vs 3D; GRE vs EPI etc.; | essential |
| Acquisition sequence commercial name | e.g. “SWAN”, “MERGE”, “SWIp”… |
|
| k-space sampling trajectory scheme | cartesian vs spiral vs radial etc. | essential, if not cartesian |
| Acquisition orientation | pure axial vs sagittal vs oblique |
|
| Number of echoes, TE1:ΔTE:TEmax | e.g. 7 echoes, TE = 5:5:35 ms | essential |
| TR | essential | |
| FA |
|
|
| Pixel Bandwidth or Receiver Bandwidth [Hz] | DICOM tag (0018, 0095) |
|
| Spatial coverage (FOV) and acquisition matrix size | essential | |
| Voxel Size | NOTE: it can be different from “FOV divided by matrix size” because images are often interpolated at reconstruction | essential |
| Monopolar vs bipolar echoes | Indicate if the sequence produces monopolar of bipolar echoes |
|
| Average ± std center frequency [MHz] | In multi-scanner studies, mean ± std center frequency shall be reported for data from each scanner. For example, Siemens “3T” scanners systematically operate at <2.9T. DICOM tag (0018,0084) | essential for multi-scanner studies; unnecessary for single-scanner studies |
| Flow compensation | Yes / no; if yes, please indicate the compensated echo(s): all vs only the first one; and direction (full, phase) |
|
| Acceleration type and factor | Yes / no. If yes: SENSE (or ASSET) vs GRAPPA (or ARC), compressed SENSE, etc.; indicate phase factor and slice factor (if 3D) | essential |
| Partial Fourier factor | Use should be avoided. If used, indicate partial Fourier factors in phase and slice direction | essential, if used |
| Partial echo (GE/Philips) aka Asymmetric echo (Siemens) aka Half echo (Hitachi) | Use should be avoided. | essential, if used |
| Elliptical k-space shutter | Yes / no. |
|
| Phase stabilization | Option available only in particular implementations. If the option is available, indicate Yes / no |
|
| Excitation pulse | Fat-sat vs Water-only |
|
| Scan duration | essential |
Table 5.
Recommendations for reporting of parameters of the reconstruction and analysis pipelines. The reporting of specific items is considered essential if there was unanimous consensus in reporting them. Items that were not considered essential were assigned a “traffic light ranking” (green, orange, red; detailed in Supporting Information IV, Section 9.3.1): it is recommended that items with a green or orange flag are reported.
| Item | Notes | Recommended |
|---|---|---|
| Toolbox used | Specify toolbox name and version (or download date), e.g. FANSI, STISuite, MEDI, etc. | essential |
| Algorithms used | For each step of the recon pipeline (phase reconstruction, echo combination, masking, phase unwrapping, background field removal, dipole inversion), please specify the algorithm used. Indicate the numerical values of relevant parameters (even if default values were used), e.g. regularization parameters. |
essential, at least for non-default algorithms and parameters |
| Further processing | If further processing was necessary to make images compatible with image review environments (such as PACS) used in the study, any data manipulation (including geometrical transformations, interpolation, header data changes, etc.) should be reported |
|
| Referencing | Magnetic susceptibility values should always be reported in either ppm or ppb (parts-per-billion) and the reference region (see the Section 8) should be explicitly stated, even in the case the adopted method did implicit whole brain referencing. When the reference region used in the study is not the whole-brain mask, its [mean ± std] susceptibility value when referenced to the whole-brain mask should be reported, to enable post-hoc re-referencing for meta-analyses. Generally, it should be discussed in the Discussion section how potential pathological changes within the reference region may have biased the study outcome. |
essential |
| Data inclusion/exclusion criteria | Details on data inclusion/exclusion criteria should be reported. For example: which artifacts were taken into consideration, and which level of artifact severity was considered as a threshold for inclusion/exclusion. The description of this aspect, which is study-specific, can be supported by images with representative cases in the Supporting Information. | essential, in studies where datasets were excluded based on image quality, or when datasets with visible artifacts were deemed acceptable for inclusion |
| Artifacts and SNR | Relevant artifacts and SNR issues should be described. | essential, at least for studies where systematic artifacts and SNR issues in the regions of interest may influence the interpretation of results. |
9.1.2. Displaying figures
When displaying quantitative susceptibility maps and the underlying phase images, avoid using rainbow, jet, or similar nonlinear colormaps, as they create false edges in some areas, conceal existing edges in others, and lack intuitive attribution 205–207. Using a linear grayscale map maintains consistency with most of the published literature. When using color, unless there is a specific reason to use a different approach, opt for a linear, perceptually uniform colormap. Adjust contrast windowing to prevent saturation of relevant brain areas. For healthy brain QSM, a typical window range is [−0.2, +0.2] ppm. Always report the windowing using an intensity bar or providing information in the figure caption. Display susceptibility values only within the background field removal mask (refer to Section 5) to avoid presenting meaningless results.
9.1.3. Interpretation of results
A potential confound that can affect the extraction of quantitative susceptibility values from MRI phase/frequency data arises from the fact that the apparent field measured in a voxel depends on the subvoxel distribution and visibility of water protons (the sensors of the MRI signal) around susceptibility perturbers (such as iron and myelin). This can cause a phase shift due to biased sampling when sensor and perturber distributions spatially correlate in an anisotropic manner 208,209. An example is water in and around myelinated fibers, whose anisotropic distribution leads to a fiber orientation-dependent shift in apparent frequency which can exceed 10 ppb 191,194,195,208–210. Furthermore, substantial T1, MT, or T2* weighting may differentially affect water visibility in different compartments and render apparent frequency shifts dependent (in a non-linear manner) on TR or TE 86,211,212. Caution is advised when interpreting QSM values within and around fibers perpendicular to B0, because pathological changes in myelin structure in the absence of changes in myelin content in such fiber bundles may lead to QSM changes without actual changes in tissue susceptibility.
Caution is necessary also with interpretation of QSM near the edge of analyzed regions (see Section 5). A notable example involves consideration of areas near the brain’s surface, where phase data is unreliable (due to, e.g., the prevalence of paramagnetic blood in pial veins), or unavailable (due to the lack of signal in skull), or the tissue phase was partially removed in the background field removal step. Because of this, QSM values in cortical grey matter may be incorrect.
Lastly, when strong regularization or prior information is used in QSM dipole inversion, potential smoothing and resolution loss may occur or new features may be added 163,213,214 (see Section 7.1). Some anatomical detail, visible in phase or magnitude GRE data, may therefore be lost in the QSM.
9.2. Consensus Recommendations
-
9.a.
Always report at least the essential information regarding the acquisition hardware (Table 3), acquisition sequence type and parameters (Table 4), reconstruction pipeline and analysis (Table 5).
-
9.b.
Representative susceptibility maps and the underlying background field-corrected phase images should be shown in all articles. Linear gray scale is often seen as best, but is not specifically recommended. The intensity windowing should always be reported using a scale bar or with pertinent information in the figure caption.
To facilitate documenting the reconstruction pipeline, we encourage software developers to output the values of all relevant parameters in Tables 4 and 5 (including default parameters) and provide suggested descriptions of their toolboxes, which users can re-utilize in their publications.
10. Summary and Conclusion
This consensus paper has been developed by the QSM Consensus Paper Committee with consideration of suggestions from the whole QSM research community (see Acknowledgements and Supporting Information I, Section S1.3). The paper provides recommendations for all steps essential in setting up a successful QSM study in a clinical research setting. The recommendations, intended for a robust but not necessarily state-of-the-art QSM, are based on the current state of the field (as of 2023) and should be updated as the QSM field progresses.
In summary, we recommend that data be acquired using a monopolar 3D multi-echo GRE sequence, and that phase images be saved and exported in DICOM format and unwrapped using a quantitative approach. Echoes should be combined before background removal, and a brain mask created using a brain extraction tool with the incorporation of phase-quality based masking. Fields from sources outside the brain should be removed using a SHARP-based or PDF technique and the optimization approach to dipole inversion should be employed with a sparsity type regularization. Susceptibility values should be measured relative to a specified reference, including the common reference region of whole brain as a region of interest in the analysis, and QSM results should be reported with – as a minimum – the acquisition and processing details listed in Tabs. 3–5.
The recommended steps for data acquisition, data preparation and post processing are intended to provide a uniform robust reference starting point for a brain-focused QSM study performed with a clinical scanner. Specialty applications, such as the depiction of small structures might require higher spatial resolution than that recommended here 215. In this regard, limitations and further considerations are included in each section, but thorough testing of the processing pipeline is recommended before beginning a large patient study.
We hope that the recommendations here will enable many medical research centers to perform comparable QSM studies on scanners from different vendors, and that the standardized acquisition protocols and the processing pipeline provided along with this article will facilitate these studies (see Supporting Information I, Section S1.4. and Supporting Information II). As more clinical QSM studies are performed, analyzed, and presented in scientific publications, and current and future technical innovations become mature, these QSM recommendations will need to be updated.
Supplementary Material
Acknowledgements
We thank Alexandra Roberts and Mert Sisman (Weill Cornell Medicine) for support with the MRI data acquisition and processing. We thank the following individuals for their significant contribution to the development of the initial consensus statements during the study group review phase: Steffen Bollmann (The University of Queensland), Marta Lancione (IRCCS Stella Maris Foundation), Jakob Meineke (Philips Research Hamburg), Xi Peng, Ludovic de Rochefort (Aix-Marseille University), Mathieu Santin (L’Institut du Cerveau et de la Moelle Épinière), Salil Soman (Harvard Medical School).
We thank the following individuals for their significant contribution to the improvement of the manuscript at and following the presentation at the 2022 Joint Workshop on MR phase, magnetic susceptibility and electrical properties mapping held in Lucca, Italy on October 16–19, 2022. Researchers providing general advice on consensus recommendations: Xavier Golay (University College London); MRI physicists supporting clinicians: Wibeke Nordhøy (Oslo University Hospital); MRI physicists working at manufacturers: Brian Burns (GE Healthcare), Kim van de Ven (Philips); Neurologists: Nicolás Crossley K. (The Pontifical Catholic University of Chile).
In addition, we thank the following ISMRM EMPT study group members, industry representatives, and clinicians who provided substantial feedback during the November/December 2022 manuscript review phase: Antje Bishof (University Hospital Münster), Yoshitaka Bito (Industry; Fujifilm), Nicolas Crossley (Pontificia Universidad Catolica de Chile), Andreas Deistung (University Hospital Halle), Cristina Granziera (University of Basel), Mark E. Haacke (Wayne State University), Marta Lancione (IRCCS Stella Maris Foundation), Emelie Lind (Lund University); Anna Lundberg (Lund University); Jie Luo (Shanghai Jiao Tong University), Jakob Meineke (Philips Research Hamburg); Kieran O’Brian (Industry; Siemens Healthineers), Alexander Rauscher (University of British Columbia), Daniel Sodickson (NYU Langone Health), Hongfu Sun (University of Queensland), Anil Man Tuladhar (Radboud University Medical Center), Anja van der Kolk (Donders Institute), Kim van de Ven (Industry; Philips); Alan Wilman (University of Alberta), Ronnie Wirestam (Lund University); Yongquan Ye (Industry; United Imaging); Xiangzhi Zhou (Mayo Clinic).
Finally, we thank Ashley Steward and Steffen Bollmann (The University of Queensland) for contributing the sections about QSMxT in Supporting Information 2.
This publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01 NS114227 (F.S.), R01 NS105144, and R01 NS095562 (Y.W.), the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1 TR001412 (F.S.), the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under Award Numbers R01 EB032378, R01 EB028797, R03 EB031175, P41 EB030006, U01 EB026996 (B.B.), U01 EB025162 (B.B., C.L.), and P41 EB031771 (P.V.Z, X.L.), the National Institute on Aging of the National Institutes of Health under Award Numbers R01 AG063842 (X.L.) and R01 AG070826 (C.L.), and the National Institute of Mental Health of the National Institutes of Health under Award Number R01 MH127104 (C.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. S.R. was supported by the Austrian Science Fund (FWF): 31452 and the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 794298. K.S. is supported by European Research Council consolidator grant DiSCo MRI SFN 770939. M.C. is supported by the Italian Ministry of Health (grant RC and 5×1000 voluntary contributions)
Footnotes
CRediT authorship contribution statement
Berkin Bilgic: Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing. Mauro Costagli: Conceptualization, Methodology, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Jeff Duyn: Writing – Review & Editing. Christian Langkammer: Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing. Jongho Lee: Conceptualization, Methodology, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Xu Li: Conceptualization, Methodology, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Chunlei Liu: Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing. José Marques: Conceptualization, Methodology, Resources, Software, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Carlos Milovic: Conceptualization, Methodology, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Simon Robinson: Conceptualization, Methodology, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Ferdinand Schweser: Conceptualization, Methodology, Project Administration (lead), Supervision (lead), Writing – Original Draft Preparation, Writing – Review & Editing (lead). Kwok-Shing Chan: Conceptualization, Data Curation, Formal Analysis, Methodology, Software (lead). Karin Shmueli: Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing. Pascal Spincemaille: Conceptualization, Methodology, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Sina Straub: Conceptualization, Methodology, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing. Peter van Zijl: Conceptualization, Writing – Review & Editing. Yi Wang: Conceptualization, Methodology, Resources, Supervision, Visualization, Writing – Original Draft Preparation (lead), Writing – Review & Editing
References
- 1.Bhattarai A, Egan GF, Talman P, Chua P, Chen Z. Magnetic Resonance Iron Imaging in Amyotrophic Lateral Sclerosis. J Magn Reson Imaging. 2022;55(5):1283–1300. doi: 10.1002/jmri.27530 [DOI] [PubMed] [Google Scholar]
- 2.Duyn JH. Studying brain microstructure with magnetic susceptibility contrast at high-field. NeuroImage. 2018;168(xxxx):152–161. doi: 10.1016/j.neuroimage.2017.02.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Eskreis-Winkler S, Zhang Y, Zhang J, et al. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning. NMR Biomed. 2017;30(4):e3668. doi: 10.1002/nbm.3668 [DOI] [PubMed] [Google Scholar]
- 4.Ghassaban K, Liu S, Jiang C, Haacke EM. Quantifying iron content in magnetic resonance imaging. NeuroImage. 2019;187:77–92. doi: 10.1016/j.neuroimage.2018.04.047 [DOI] [PubMed] [Google Scholar]
- 5.Liu C, Wei H, Gong N jie, Cronin MJ, Dibb R, Decker K. Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications. Tomography. 2015;1(1):3–17. doi: 10.18383/j.tom.2015.00136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nikparast F, Ganji Z, Zare H. Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder? BMC Neurosci. 2022;23(1):48. doi: 10.1186/s12868-022-00725-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nikparast F, Ganji Z, Danesh Doust M, Faraji R, Zare H. Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? Insights Imaging. 2022;13(1):74. doi: 10.1186/s13244-022-01207-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Plantinga BR, Temel Y, Roebroeck A, et al. Ultra-high field magnetic resonance imaging of the basal ganglia and related structures. Front Hum Neurosci. 2014;8(November):876. doi: 10.3389/fnhum.2014.00876 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ravanfar P, Loi SM, Syeda WT, et al. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Front Neurosci. 2021;15:618435. doi: 10.3389/fnins.2021.618435 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ropele S Applications of susceptibility-weighted imaging and mapping. In: Advances in Magnetic Resonance Technology and Applications. Vol 4. Elsevier; 2021:359–369. doi: 10.1016/B978-0-12-822479-3.00037-3 [DOI] [Google Scholar]
- 11.Ropele S, Langkammer C. Iron quantification with susceptibility. NMR Biomed. 2017;30(4):e3534. doi: 10.1002/nbm.3534 [DOI] [PubMed] [Google Scholar]
- 12.Stüber C, Pitt D, Wang Y. Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping. Int J Mol Sci. 2016;17(1):100. doi: 10.3390/ijms17010100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Vinayagamani S, Sheelakumari R, Sabarish S, et al. Quantitative Susceptibility Mapping: Technical Considerations and Clinical Applications in Neuroimaging. J Magn Reson Imaging. 2021;53(1):23–37. doi: 10.1002/jmri.27058 [DOI] [PubMed] [Google Scholar]
- 14.Wang C, Foxley S, Ansorge O, et al. Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis. NeuroImage. 2020;222:117216. doi: 10.1016/j.neuroimage.2020.117216 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wang Y, Spincemaille P, Liu Z, et al. Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care. J Magn Reson Imaging. 2017;46(4):951–971. doi: 10.1002/jmri.25693 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chen W, Zhu W, Kovanlikaya I, et al. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping. Radiology. 2014;270(2):496–505. doi: 10.1148/radiol.13122640 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Deistung A, Schweser F, Wiestler B, et al. Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma. Kleinschnitz C, ed. PLoS ONE. 2013;8(3):e57924. doi: 10.1371/journal.pone.0057924 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Schweser F, Deistung A, Lehr BW, Reichenbach JR. Differentiation Between Diamagnetic and Paramagnetic Cerebral Lesions Based on Magnetic Susceptibility Mapping. Med Phys. 2010;37(10):5165–5178. doi: 10.1118/1.3481505 [DOI] [PubMed] [Google Scholar]
- 19.Straub S, Laun FB, Emmerich J, et al. Potential of quantitative susceptibility mapping for detection of prostatic calcifications. J Magn Reson Imaging. 2017;45(3):889–898. doi: 10.1002/jmri.25385 [DOI] [PubMed] [Google Scholar]
- 20.Chen J, Gong NJ, Chaim KT, Otaduy MCG, Liu C. Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data. NeuroImage. 2021;242:118477. doi: 10.1016/j.neuroimage.2021.118477 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dimov AV, Nguyen TD, Gillen KM, et al. Susceptibility source separation from gradient echo data using magnitude decay modeling. J Neuroimaging. June 2022:jon.13014. doi: 10.1111/jon.13014 [DOI] [PubMed] [Google Scholar]
- 22.Dimov AV, Gillen KM, Nguyen TD, et al. Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation. Tomography. 2022;8(3):1544–1551. doi: 10.3390/tomography8030127 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Elkady AM, Cobzas D, Sun H, Blevins G, Wilman AH. Discriminative analysis of regional evolution of iron and myelin/calcium in deep gray matter of multiple sclerosis and healthy subjects. J Magn Reson Imaging. 2018;48(3):652–668. doi: 10.1002/jmri.26004 [DOI] [PubMed] [Google Scholar]
- 24.Emmerich J, Bachert P, Ladd ME, Straub S. On the separation of susceptibility sources in quantitative susceptibility mapping: Theory and phantom validation with an in vivo application to multiple sclerosis lesions of different age. J Magn Reson. 2021;330:107033. doi: 10.1016/j.jmr.2021.107033 [DOI] [PubMed] [Google Scholar]
- 25.Li J, Lin H, Liu T, et al. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration: QSM Minimizes R2* Cellular Interference. J Magn Reson Imaging. 2018;48(4):1069–1079. doi: 10.1002/jmri.26019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Schweser F, Deistung A, Lehr BW, Sommer K, Reichenbach JR. SEMI-TWInS: Simultaneous Extraction of Myelin and Iron using a T2*-Weighted Imaging Sequence. In: Proc Intl Soc Mag Reson Med 19 (2011). Montreal, CA; 2011:120. [Google Scholar]
- 27.Shin HG, Lee J, Yun YH, et al. χ-separation: Magnetic susceptibility source separation toward iron and myelin mapping in the brain. NeuroImage. 2021;240:118371. doi: 10.1016/j.neuroimage.2021.118371 [DOI] [PubMed] [Google Scholar]
- 28.Stüber C, Morawski M, Schäfer A, et al. Myelin and iron concentration in the human brain: A quantitative study of MRI contrast. NeuroImage. 2014;93:95–106. doi: 10.1016/j.neuroimage.2014.02.026 [DOI] [PubMed] [Google Scholar]
- 29.Yablonskiy DA, Wen J, Kothapalli SVVN, Sukstanskii AL. In vivo evaluation of heme and non-heme iron content and neuronal density in human basal ganglia. NeuroImage. 2021;235:118012. doi: 10.1016/j.neuroimage.2021.118012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Cong F, Liu X, Liu CJ, et al. Improved depiction of subthalamic nucleus and globus pallidus internus with optimized high-resolution quantitative susceptibility mapping at 7 T. NMR Biomed. July 2020. doi: 10.1002/nbm.4382 [DOI] [PubMed] [Google Scholar]
- 31.Deistung A, Schäfer A, Schweser F, Biedermann U, Turner R, Reichenbach JR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. NeuroImage. 2013;65:299–314. doi: 10.1016/j.neuroimage.2012.09.055 [DOI] [PubMed] [Google Scholar]
- 32.Li J, Li Y, Gutierrez L, et al. Imaging the Centromedian Thalamic Nucleus Using Quantitative Susceptibility Mapping. Front Hum Neurosci. 2020;13:447. doi: 10.3389/fnhum.2019.00447 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Feng X, Deistung A, Dwyer MG, et al. An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM). Magn Reson Imaging. 2017;39:110–122. doi: 10.1016/j.mri.2017.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hanspach J, Dwyer MG, Bergsland NP, et al. Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA). J Magn Reson Imaging. 2017;46(5):1474–1484. doi: 10.1002/jmri.25671 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chandran AS, Bynevelt M, Lind CRP. Magnetic resonance imaging of the subthalamic nucleus for deep brain stimulation. J Neurosurg. August 2015:1–10. doi: 10.3171/2015.1.JNS142066 [DOI] [PubMed] [Google Scholar]
- 36.de Hollander G, Keuken MC, Bazin PL, et al. A gradual increase of iron toward the medial-inferior tip of the subthalamic nucleus. Hum Brain Mapp. 2014;00. doi: 10.1002/hbm.22485 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Liu T, Eskreis-Winkler S, Schweitzer AD, et al. Improved Subthalamic Nucleus Depiction with Quantitative Susceptibility Mapping. Radiology. 2013;(7):1–10. doi: 10.1148/radiol.13121991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rasouli J, Ramdhani R, Panov FE, et al. Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. Oper Neurosurg. 2018;14(4):412–419. doi: 10.1093/ons/opx131 [DOI] [PubMed] [Google Scholar]
- 39.Wei H, Zhang C, Wang T, et al. Precise targeting of the globus pallidus internus with quantitative susceptibility mapping for deep brain stimulation surgery. J Neurosurg. October 2019:1–7. doi: 10.3171/2019.7.JNS191254 [DOI] [PubMed] [Google Scholar]
- 40.Ravanfar P, Syeda WT, Jayaram M, et al. In Vivo 7-Tesla MRI Investigation of Brain Iron and Its Metabolic Correlates in Chronic Schizophrenia. Schizophrenia. 2022;8(1):86. doi: 10.1038/s41537-022-00293-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Xu M, Guo Y, Cheng J, et al. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping. NeuroImage Clin. 2021;31:102736. doi: 10.1016/j.nicl.2021.102736 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zhang W, Zhou Y, Li Q, et al. Brain Iron Deposits in Thalamus Is an Independent Factor for Depressive Symptoms Based on Quantitative Susceptibility Mapping in an Older Adults Community Population. Front Psychiatry. 2019;10:734. doi: 10.3389/fpsyt.2019.00734 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Yao S, Zhong Y, Xu Y, et al. Quantitative Susceptibility Mapping Reveals an Association between Brain Iron Load and Depression Severity. Front Hum Neurosci. 2017;11(August):1–8. doi: 10.3389/fnhum.2017.00442 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Cao W, Li W, Han H, et al. Prenatal alcohol exposure reduces magnetic susceptibility contrast and anisotropy in the white matter of mouse brains. NeuroImage. August 2014. doi: 10.1016/j.neuroimage.2014.08.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Juhás M, Sun H, Brown MRG, et al. Deep Grey Matter Iron Accumulation in Alcohol Use Disorder. NeuroImage. 2017;148(January):115–122. doi: 10.1016/j.neuroimage.2017.01.007 [DOI] [PubMed] [Google Scholar]
- 46.Wang C, Martins-Bach AB, Alfaro-Almagro F, et al. Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging. Nat Neurosci. 2022;25(6):818–831. doi: 10.1038/s41593-022-01074-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Li Y, Sethi SK, Zhang C, et al. Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study. Front Neurosci. 2021;14:607705. doi: 10.3389/fnins.2020.607705 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Deh K, Nguyen TD, Eskreis-Winkler S, et al. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors. J Magn Reson Imaging. 2015;42(6):1592–1600. doi: 10.1002/jmri.24943 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Aimo A, Huang L, Tyler A, et al. Quantitative susceptibility mapping (QSM) of the cardiovascular system: challenges and perspectives. J Cardiovasc Magn Reson. 2022;24(1):48. doi: 10.1186/s12968-022-00883-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Bilgic B, Chatnuntawech I, Polak D. Chapter 16 - Quantitative Susceptibility-Mapping Reconstruction. In: Akçakaya M, Doneva M, Prieto C, eds. Advances in Magnetic Resonance Technology and Applications. Vol 7. Magnetic Resonance Image Reconstruction. Academic Press; 2022:441–467. doi: 10.1016/B978-0-12-822726-8.00027-0 [DOI] [Google Scholar]
- 51.Bilgic B, Chatnuntawech I, Langkammer C, Setsompop K. Sparse methods for Quantitative Susceptibility Mapping. SPIE. 2015;9597:959711. doi: 10.1117/12.2188535 [DOI] [Google Scholar]
- 52.Chung J, Ruthotto L. Computational methods for image reconstruction. NMR Biomed. 2017;30(4). doi: 10.1002/nbm.3545 [DOI] [PubMed] [Google Scholar]
- 53.Gozt A, Hellewell S, Ward PGD, Bynevelt M, Fitzgerald M. Emerging Applications for Quantitative Susceptibility Mapping in the Detection of Traumatic Brain Injury Pathology. Neuroscience. 2021;467:218–236. doi: 10.1016/j.neuroscience.2021.05.030 [DOI] [PubMed] [Google Scholar]
- 54.Jung W, Bollmann S, Lee J. Overview of quantitative susceptibility mapping using deep learning: Current status, challenges and opportunities. NMR Biomed. March 2020:e4292. doi: 10.1002/nbm.4292 [DOI] [PubMed] [Google Scholar]
- 55.Kee Y, Liu Z, Zhou L, et al. Quantitative Susceptibility Mapping (QSM) Algorithms: Mathematical Rationale and Computational Implementations. IEEE Trans Biomed Eng. 2017;14(8):1–1. doi: 10.1109/TBME.2017.2749298 [DOI] [PubMed] [Google Scholar]
- 56.Robinson SD, Bredies K, Khabipova D, Dymerska B, Marques JP, Schweser F. An illustrated comparison of processing methods for MR phase imaging and QSM: combining array coil signals and phase unwrapping. NMR Biomed. 2017;30(4):e3601. doi: 10.1002/nbm.3601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Schweser F, Robinson SD, de Rochefort L, Li W, Bredies K. An illustrated comparison of processing methods for phase MRI and QSM: removal of background field contributions from sources outside the region of interest. NMR Biomed. 2017;30(4):e3604. doi: 10.1002/nbm.3604 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Schweser F, Deistung A, Reichenbach JR. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM). Z Med Phys. 2016;26(1):6–34. doi: 10.1016/j.zemedi.2015.10.002 [DOI] [PubMed] [Google Scholar]
- 59.Shmueli K. Chapter 31 - Quantitative Susceptibility Mapping. In: Seiberlich N, Gulani V, Calamante F, et al. , eds. Advances in Magnetic Resonance Technology and Applications. Vol 1. Quantitative Magnetic Resonance Imaging. Academic Press; 2020:819–838. doi: 10.1016/B978-0-12-817057-1.00033-0 [DOI] [Google Scholar]
- 60.Uchida Y, Kan H, Sakurai K, Oishi K, Matsukawa N. Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations. Front Neurosci. 2022;16:938092. doi: 10.3389/fnins.2022.938092 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Wang Y, Liu T. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magn Reson Med. 2015;73(1):82–101. doi: 10.1002/mrm.25358 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Haacke EM, Liu S, Buch S, Zheng W, Wu D, Ye Y. Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging. 2015;33(1):1–25. doi: 10.1016/j.mri.2014.09.004 [DOI] [PubMed] [Google Scholar]
- 63.Langkammer C, Schweser F, Shmueli K, et al. Quantitative susceptibility mapping: Report from the 2016 reconstruction challenge. Magn Reson Med. 2018;79(3):1661–1673. doi: 10.1002/mrm.26830 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Marques JP, Meineke J, Milovic C, et al. QSM reconstruction challenge 2.0: A realistic in silico head phantom for MRI data simulation and evaluation of susceptibility mapping procedures. Magn Reson Med. 2021;86(1):526–542. doi: 10.1002/mrm.28716 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Milovic C, Tejos C, Acosta-Cabronero J, et al. The 2016 QSM Challenge: Lessons learned and considerations for a future challenge design. Magn Reson Med. 2020;84(3):1624–1637. doi: 10.1002/mrm.28185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.QSM Challenge 2.0 Organization Committee, Bilgic B, Langkammer C, et al. QSM reconstruction challenge 2.0: Design and report of results. Magn Reson Med. 2021;86(3):1241–1255. doi: 10.1002/mrm.28754 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.AlTokhis AI, AlOtaibi AM, Felmban GA, Constantinescu CS, Evangelou N. Iron Rims as an Imaging Biomarker in MS: A Systematic Mapping Review. Diagnostics. 2020;10(11):968. doi: 10.3390/diagnostics10110968 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Calvi A, Haider L, Prados F, Tur C, Chard D, Barkhof F. In vivo imaging of chronic active lesions in multiple sclerosis. Mult Scler J. 2022;28(5):683–690. doi: 10.1177/1352458520958589 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Gillen KM, Mubarak M, Park C, et al. QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions. Ann Clin Transl Neurol. March 2021:acn3.51338. doi: 10.1002/acn3.51338 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Huang W, Sweeney EM, Kaunzner UW, Wang Y, Gauthier SA, Nguyen TD. Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination. J Neuroimaging. 2022;n/a(n/a). doi: 10.1111/jon.12987 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Jang J, Nam Y, Choi Y, et al. Paramagnetic Rims in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Quantitative Susceptibility Mapping Study with 3-T MRI. J Clin Neurol. 2020;16(4):562. doi: 10.3988/jcn.2020.16.4.562 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Marcille M, Hurtado Rúa S, Tyshkov C, et al. Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis. Sci Rep. 2022;12(1):4411. doi: 10.1038/s41598-022-08477-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ng Kee Kwong KC, Mollison D, Meijboom R, et al. The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis. Jiang Q, ed. PLOS ONE. 2021;16(9):e0256845. doi: 10.1371/journal.pone.0256845 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Rahmanzadeh R, Lu PJ, Barakovic M, et al. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging. Brain. 2021;144(6):1684–1696. doi: 10.1093/brain/awab088 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Tolaymat B, W Z, H C, S C, X L, Dm H. Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping. Mult Scler Relat Disord. 2020;45:102317. doi: 10.1016/j.msard.2020.102317 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Chan KS, Marques JP. SEPIA—Susceptibility mapping pipeline tool for phase images. NeuroImage. 2021;227:117611. doi: 10.1016/j.neuroimage.2020.117611 [DOI] [PubMed] [Google Scholar]
- 77.Bilgic B, Costagli M, Chan KS, et al. Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group. July 2023. doi: 10.48550/arXiv.2307.02306 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Karsa A, Punwani S, Shmueli K. The effect of low resolution and coverage on the accuracy of susceptibility mapping. Magn Reson Med. 2019;81(3):1833–1848. doi: 10.1002/mrm.27542 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Wei H, Zhang Y, Gibbs E, Chen NK, Wang N, Liu C. Joint 2D and 3D phase processing for quantitative susceptibility mapping: Application to 2D echo-planar imaging. NMR Biomed. 2016;(October 2015). doi: 10.1002/nbm.3501 [DOI] [PubMed] [Google Scholar]
- 80.Li J, Chang S, Liu T, et al. Phase-corrected bipolar gradients in multi-echo gradient-echo sequences for quantitative susceptibility mapping. Magn Reson Mater Phy. 2015;(28):347–355. doi: 10.1007/s10334-014-0470-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Berg RC, Preibisch C, Thomas DL, Shmueli K, Biondetti E. Investigating the effect of flow compensation and quantitative susceptibility mapping method on the accuracy of venous susceptibility measurement. NeuroImage. 2021;240:118399. doi: 10.1016/j.neuroimage.2021.118399 [DOI] [PubMed] [Google Scholar]
- 82.Cronin MJ, Wharton SJ, Al-Radaideh AM, et al. A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field. Magn Reson Mater Phys Biol Med. 2016:1–15. doi: 10.1007/s10334-016-0560-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47(6):1202–1210. doi: 10.1002/mrm.10171 [DOI] [PubMed] [Google Scholar]
- 84.Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med. 1999;42(5):952–962. [PubMed] [Google Scholar]
- 85.Sodickson DK, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): Fast imaging with radiofrequency coil arrays. Magn Reson Med. 1997;38(4):591–603. doi: 10.1002/mrm.1910380414 [DOI] [PubMed] [Google Scholar]
- 86.Cronin MJ, Wang N, Decker KS, Wei H, Zhu WZ, Liu C. Exploring the origins of echo-time-dependent quantitative susceptibility mapping (QSM) measurements in healthy tissue and cerebral microbleeds. NeuroImage. 2017;149:98–113. doi: 10.1016/j.neuroimage.2017.01.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Liu J, Wang Y, Katscher U, He B. Electrical Properties Tomography Based on $B_{{1}}$ Maps in MRI: Principles, Applications, and Challenges. IEEE Trans Biomed Eng. 2017;64(11):2515–2530. doi: 10.1109/TBME.2017.2725140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Metere R, Kober T, Möller HE, Schäfer A. Simultaneous Quantitative MRI Mapping of T1, T2* and Magnetic Susceptibility with Multi-Echo MP2RAGE. Grolmusz V, ed. PLOS ONE. 2017;12(1):e0169265. doi: 10.1371/journal.pone.0169265 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM. The NMR phased array. Magn Reson Med. 1990;16(2):192–225. [DOI] [PubMed] [Google Scholar]
- 90.Li X, Morgan PS, Ashburner J, Smith J, Rorden C. The first step for neuroimaging data analysis: DICOM to NIfTI conversion. J Neurosci Methods. 2016;264:47–56. doi: 10.1016/j.jneumeth.2016.03.001 [DOI] [PubMed] [Google Scholar]
- 91.Hagberg GE, Welch EB, Greiser A. The sign convention for phase values on different vendor systems: definition and implications for susceptibility-weighted imaging. Magn Reson Imaging. 2010;28(2):297–300. doi: 10.1016/j.mri.2009.06.001 [DOI] [PubMed] [Google Scholar]
- 92.Jell V, Kannengiesser SAR. Adaptive Coil Combination Using a Body Coil Scan as Phase Reference. In: Proc GC Intl Soc Mag Reson Med 17 (2014). Milan, Italy; 2014:p4406. [Google Scholar]
- 93.Feng W, Neelavalli J, Haacke EM. Catalytic multiecho phase unwrapping scheme (CAMPUS) in multiecho gradient echo imaging: removing phase wraps on a voxel-by-voxel basis. Magn Reson Med. 2013;70(1):117–126. doi: 10.1002/mrm.24457 [DOI] [PubMed] [Google Scholar]
- 94.Robinson SD, Schödl H, Trattnig S. A method for unwrapping highly wrapped multi-echo phase images at very high field: UMPIRE. Magn Reson Med. 2014;72(1):80–92. doi: 10.1002/mrm.24897 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Jenkinson M A Fast, Automated, N-Dimensional Phase-Unwrapping Algorithm. Magn Reson Med. 2003;49:193–197. [DOI] [PubMed] [Google Scholar]
- 96.Karsa A, Shmueli K. SEGUE: a Speedy rEgion-Growing algorithm for Unwrapping Estimated phase. IEEE Trans Med Imaging. 2018:1–1. doi: 10.1109/TMI.2018.2884093 [DOI] [PubMed] [Google Scholar]
- 97.Witoszynskyj S, Rauscher A, Reichenbach JR, Barth M. Phase unwrapping of MR images using Phi UN--a fast and robust region growing algorithm. Med Image Anal. 2009;13(2):257–268. [DOI] [PubMed] [Google Scholar]
- 98.Ye Y, Zhou F, Zong J, et al. Seed prioritized unwrapping (SPUN) for MR phase imaging: SPUN Method. J Magn Reson Imaging. December 2018. doi: 10.1002/jmri.26606 [DOI] [PubMed] [Google Scholar]
- 99.Abdul-Rahman HS, Gdeisat MA, Burton DR, Lalor MJ, Lilley F, Moore CJ. Fast and robust three-dimensional best path phase unwrapping algorithm. Appl Opt. 2007;46(26):6623–6635. [DOI] [PubMed] [Google Scholar]
- 100.Dymerska B, Eckstein K, Bachrata B, et al. Phase unwrapping with a rapid opensource minimum spanning tree algorithm (ROMEO). Magn Reson Med. 2021;85(4):2294–2308. doi: 10.1002/mrm.28563 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Schofield MA, Zhu Y. Fast phase unwrapping algorithm for interferometric applications. Opt Lett. 2003;28(14):1194–1196. [DOI] [PubMed] [Google Scholar]
- 102.Milovic C, Bilgic B, Zhao B, Langkammer C, Tejos C, Acosta-Cabronero J. Weak-harmonic regularization for quantitative susceptibility mapping. Magn Reson Med. 2019;81(2):1399–1411. doi: 10.1002/mrm.27483 [DOI] [PubMed] [Google Scholar]
- 103.Hsieh MC, Tsai CY, Liao MC, Yang JL, Su CH, Chen JH. Quantitative susceptibility mapping-based microscopy of magnetic resonance venography (QSM-mMRV) for in vivo morphologically and functionally assessing cerebromicrovasculature in rat stroke model. PLoS ONE. 2016;11(3):1–22. doi: 10.1371/journal.pone.0149602 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Sun H, Kate M, Gioia LC, Emery DJ, Butcher K, Wilman AH. Quantitative susceptibility mapping using a superposed dipole inversion method: Application to intracranial hemorrhage. Magn Reson Med. 2015;791:781–791. doi: 10.1002/mrm.25919 [DOI] [PubMed] [Google Scholar]
- 105.Biondetti E, Karsa A, Thomas DL, Shmueli K. Investigating the accuracy and precision of TE-dependent versus multi-echo QSM using Laplacian-based methods at 3 T. Magn Reson Med. 2020;84(6):3040–3053. doi: 10.1002/mrm.28331 [DOI] [PubMed] [Google Scholar]
- 106.Liu T, Wisnieff C, Lou M, Chen W, Spincemaille P, Wang Y. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn Reson Med. 2013;69(2):467–476. doi: 10.1002/mrm.24272 [DOI] [PubMed] [Google Scholar]
- 107.Wu B, Li W, Avram AV, Gho SM, Liu C. Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals. NeuroImage. 2012;59(1):297–305. doi: 10.1016/j.neuroimage.2011.07.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Chen L, Cai S, van Zijl PCM, Li X. Single-step calculation of susceptibility through multiple orientation sampling. NMR Biomed. 2021;34(7):e4517. doi: 10.1002/nbm.4517 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Kressler B, de Rochefort L, Liu T, Spincemaille P, Jiang Q, Wang Y. Nonlinear regularization for per voxel estimation of magnetic susceptibility distributions from MRI field maps. IEEE Trans Med Imaging. 2010;29(2):273–281. doi: 10.1109/TMI.2009.2023787 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Eckstein K, Dymerska B, Bachrata B, et al. Computationally Efficient Combination of Multi-channel Phase Data From Multi-echo Acquisitions (ASPIRE): Combination of Multi-Channel Phase Data from Multi-Echo Acquisitions (ASPIRE). Magn Reson Med. 2018;79(6):2996–3006. doi: 10.1002/mrm.26963 [DOI] [PubMed] [Google Scholar]
- 111.Stewart AW, Robinson SD, O’Brien K, et al. QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping. Magn Reson Med. 2022;87(3):1289–1300. doi: 10.1002/mrm.29048 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Arrieta C, Sing-Long CA, Mura J, et al. Level set segmentation with shape prior knowledge using intrinsic rotation, translation and scaling alignment. Biomed Signal Process Control. 2021;63:102241. doi: 10.1016/j.bspc.2020.102241 [DOI] [Google Scholar]
- 113.Caselles V, Catté F, Coll T, Dibos F. A geometric model for active contours in image processing. Numer Math. 1993;66(1):1–31. doi: 10.1007/BF01385685 [DOI] [Google Scholar]
- 114.Chan TF, Vese LA. Active contours without edges. IEEE Trans Image Process. 2001;10(2):266–277. doi: 10.1109/83.902291 [DOI] [PubMed] [Google Scholar]
- 115.Cootes TF, Edwards GJ, Taylor CJ. Active appearance models. IEEE Trans Pattern Anal Mach Intell. 2001;23(6):681–685. doi: 10.1109/34.927467 [DOI] [Google Scholar]
- 116.Niessen WJ, Romeny BMTH, Viergever MA. Geodesic deformable models for medical image analysis. IEEE Trans Med Imaging. 1998;17(4):634–641. doi: 10.1109/42.730407 [DOI] [PubMed] [Google Scholar]
- 117.Suri JS, Liu K, Singh S, Laxminarayan SN, Zeng X, Reden L. Shape recovery algorithms using level sets in 2-D/3-D medical imagery: a state-of-the-art review. IEEE Trans Inf Technol Biomed. 2002;6(1):8–28. doi: 10.1109/4233.992158 [DOI] [PubMed] [Google Scholar]
- 118.Tejos C, Irarrazaval P, Cárdenas-Blanco A. Simplex Mesh Diffusion Snakes: Integrating 2D and 3D Deformable Models and Statistical Shape Knowledge in a Variational Framework. Int J Comput Vis. 2009;85(1):19–34. doi: 10.1007/s11263-009-0241-1 [DOI] [Google Scholar]
- 119.Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17(3):143–155. doi: 10.1002/hbm.10062 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Fennema-Notestine C, Ozyurt IB, Clark CP, et al. Quantitative evaluation of automated skull-stripping methods applied to contemporary and legacy images: Effects of diagnosis, bias correction, and slice location. Hum Brain Mapp. 2006;27(2):99–113. doi: 10.1002/hbm.20161 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Speier W, Iglesias JE, El-Kara L, Tu Z, Arnold C. Robust Skull Stripping of Clinical Glioblastoma Multiforme Data. In: Fichtinger G, Martel A, Peters T, eds. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2011. Lecture Notes in Computer Science. Berlin, Heidelberg: Springer; 2011:659–666. doi: 10.1007/978-3-642-23626-6_81 [DOI] [PubMed] [Google Scholar]
- 122.Karsa A, Punwani S, Shmueli K. An optimized and highly repeatable MRI acquisition and processing pipeline for quantitative susceptibility mapping in the head-and-neck region. Magn Reson Med. 2020;84(6):3206–3222. doi: 10.1002/mrm.28377 [DOI] [PubMed] [Google Scholar]
- 123.Lutkenhoff ES, Rosenberg M, Chiang J, et al. Optimized Brain Extraction for Pathological Brains (optiBET). PLOS ONE. 2014;9(12):e115551. doi: 10.1371/journal.pone.0115551 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Allioui H, Sadgal M, Elfazziki A. Deep MRI Segmentation: A Convolutional Method Applied to Alzheimer Disease Detection. Int J Adv Comput Sci Appl. 2019;10(11). doi: 10.14569/IJACSA.2019.0101151 [DOI] [Google Scholar]
- 125.Ronneberger O, Fischer P, Brox T. U-Net: Convolutional Networks for Biomedical Image Segmentation. In: Navab N, Hornegger J, Wells WM, Frangi AF, eds. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. Lecture Notes in Computer Science. Cham: Springer International Publishing; 2015:234–241. doi: 10.1007/978-3-319-24574-4_28 [DOI] [Google Scholar]
- 126.Shrivastava S, Singh N, Mishra U, Chandra A, Verma S. Comparative Study of Deep Learning Models for Segmentation of Corpus Callosum. In: 2020 Fourth International Conference on Computing Methodologies and Communication (ICCMC).; 2020:418–423. doi: 10.1109/ICCMC48092.2020.ICCMC-00079 [DOI] [Google Scholar]
- 127.Zhang Y, Wu J, Liu Y, et al. A deep learning framework for pancreas segmentation with multi-atlas registration and 3D level-set. Med Image Anal. 2021;68:101884. doi: 10.1016/j.media.2020.101884 [DOI] [PubMed] [Google Scholar]
- 128.Zhao M, Huang L, Zhang Q, Su X, Asundi A, Kemao Q. Quality-guided phase unwrapping technique: comparison of quality maps and guiding strategies. Appl Opt. 2011;50(33):6214–6224. doi: 10.1364/AO.50.006214 [DOI] [PubMed] [Google Scholar]
- 129.Lindemeyer J, Worthoff WA, Shymanskaya A, Shah NJ. Iterative Restoration of the Fringe Phase (REFRASE) for QSM. Front Neurosci. 2021;15. https://www.frontiersin.org/articles/10.3389/fnins.2021.537666. Accessed October 24, 2022. [DOI] [PMC free article] [PubMed]
- 130.Bollmann S, Kristensen MH, Larsen MS, et al. SHARQnet – Sophisticated harmonic artifact reduction in quantitative susceptibility mapping using a deep convolutional neural network. Z Für Med Phys. February 2019. doi: 10.1016/j.zemedi.2019.01.001 [DOI] [PubMed] [Google Scholar]
- 131.Gao Y, Xiong Z, Fazlollahi A, et al. Instant tissue field and magnetic susceptibility mapping from MRI raw phase using Laplacian enhanced deep neural networks. NeuroImage. 2022;259:119410. doi: 10.1016/j.neuroimage.2022.119410 [DOI] [PubMed] [Google Scholar]
- 132.Wei H, Cao S, Zhang Y, et al. Learning-based single-step quantitative susceptibility mapping reconstruction without brain extraction. NeuroImage. 2019;202:116064. doi: 10.1016/j.neuroimage.2019.116064 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Zhu X, Gao Y, Liu F, Crozier S, Sun H. BFRnet: A deep learning-based MR background field removal method for QSM of the brain containing significant pathological susceptibility sources. April 2022. doi: 10.48550/arXiv.2204.02760 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Hanspach J, Bollmann S, Grigo J, Karius A, Uder M, Laun FB. Deep learning–based quantitative susceptibility mapping (QSM) in the presence of fat using synthetically generated multi-echo phase training data. Magn Reson Med. 2022;88(4):1548–1560. doi: 10.1002/mrm.29265 [DOI] [PubMed] [Google Scholar]
- 135.Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys. 1996;23(6):815–850. [DOI] [PubMed] [Google Scholar]
- 136.Zhou D, Liu T, Spincemaille P, Wang Y. Background field removal by solving the Laplacian boundary value problem. NMR Biomed. 2014;27(3):312–319. doi: 10.1002/nbm.3064 [DOI] [PubMed] [Google Scholar]
- 137.Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? NeuroImage. 2011;54(4):2789–2807. doi: 10.1016/j.neuroimage.2010.10.070 [DOI] [PubMed] [Google Scholar]
- 138.Wu B, Li W, Guidon A, Liu C. Whole brain susceptibility mapping using compressed sensing. Magn Reson Med. 2011;24:1129–1136. doi: 10.1002/mrm.23000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Topfer R, Schweser F, Deistung A, Reichenbach JR, Wilman AH. SHARP edges: Recovering cortical phase contrast through harmonic extension. Magn Reson Med. 2015;73(2):851–856. doi: 10.1002/mrm.25148 [DOI] [PubMed] [Google Scholar]
- 140.Fang J, Bao L, Li X, van Zijl PCM, Chen Z. Background field removal for susceptibility mapping of human brain with large susceptibility variations: Susceptibility Mapping of Human Brain. Magn Reson Med. October 2018. doi: 10.1002/mrm.27492 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Wen Y, Zhou D, Liu T, Spincemaille P, Wang Y. An iterative spherical mean value method for background field removal in MRI. Magn Reson Med. 2014;72(4):1065–1071. doi: 10.1002/mrm.24998 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Li W, Avram AV, Wu B, Xiao X, Liu C. Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed. 2014;27(2):219–227. doi: 10.1002/nbm.3056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Özbay PS, Deistung A, Feng X, Nanz D, Reichenbach JR, Schweser F. A comprehensive numerical analysis of background phase correction with V-SHARP. NMR Biomed. 2017;30(4):e3550. doi: 10.1002/nbm.3550 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Liu T, Khalidov I, de Rochefort L, et al. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed. 2011;24:1129–1136. doi: 10.1002/nbm.1670 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Wharton SJ, Schäfer A, Bowtell RW. Susceptibility mapping in the human brain using threshold-based k-space division. Magn Reson Med. 2010;63(5):1292–1304. doi: 10.1002/mrm.22334 [DOI] [PubMed] [Google Scholar]
- 146.Milovic C, Fuchs P, Arsenov O, et al. Exhaustive Comparison of QSM Background Field Removal and Masking using a Realistic Numerical Head Phantom. In: Proc Intl Soc Mag Reson Med 31 (2023). Toronto, ON, Canada. [Google Scholar]
- 147.Liu Z, Spincemaille P, Yao Y, Zhang Y, Wang Y. MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping. Magn Reson Med. 2018;79(5):2795–2803. doi: 10.1002/mrm.26946 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Straub S, Schneider TM, Emmerich J, et al. Suitable reference tissues for quantitative susceptibility mapping of the brain. Magn Reson Med. 2016;00(9):3–6. doi: 10.1002/mrm.26369 [DOI] [PubMed] [Google Scholar]
- 149.Koch KM, Papademetris X, Rothman DL, de Graaf R a. Rapid calculations of susceptibility-induced magnetostatic field perturbations for in vivo magnetic resonance. Phys Med Biol. 2006;51(24):6381–6402. doi: 10.1088/0031-9155/51/24/007 [DOI] [PubMed] [Google Scholar]
- 150.Marques JP, Bowtell RW. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts Magn Reson Part B Magn Reson Eng. 2005;25B(1):65–78. doi: 10.1002/cmr.b.20034 [DOI] [Google Scholar]
- 151.Salomir R, de Senneville BD, Moonen CTW. A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility. Concepts Magn Reson Part B Magn Reson Eng. 2003;19B(1):26–34. doi: 10.1002/cmr.b.10083 [DOI] [Google Scholar]
- 152.Haacke EM, Cheng YCN, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23(1):1–25. doi: 10.1016/j.mri.2004.10.001 [DOI] [PubMed] [Google Scholar]
- 153.de Rochefort L, Brown R, Prince MR, Wang Y. Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn Reson Med. 2008;60(4):1003–1009. doi: 10.1002/mrm.21710 [DOI] [PubMed] [Google Scholar]
- 154.Li LZ, Leigh JS. Quantifying arbitrary magnetic susceptibility distributions with MR. Magn Reson Med. 2004;51(5):1077–1082. doi: 10.1002/mrm.20054 [DOI] [PubMed] [Google Scholar]
- 155.Liu T, Spincemaille P, de Rochefort L, Kressler B, Wang Y. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn Reson Med. 2009;61(1):196–204. doi: 10.1002/mrm.21828 [DOI] [PubMed] [Google Scholar]
- 156.Shmueli K, de Zwart JA, van Gelderen P, Li TQ, Dodd SJ, Duyn JH. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med. 2009;62(6):1510–1522. doi: 10.1002/mrm.22135 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Choi JK, Park HS, Wang S, Wang Y, Seo JK. Inverse Problem in Quantitative Susceptibility Mapping. SIAM J Imag Sci. 2014;7(3):1669–1689. doi: 10.1137/140957433 [DOI] [Google Scholar]
- 158.Bao L, Li X, Cai C, Chen Z, van Zijl PCM. Quantitative Susceptibility Mapping Using Structural Feature Based Collaborative Reconstruction (SFCR) in the Human Brain. IEEE Trans Med Imaging. 2016;35(9):2040–2050. doi: 10.1109/TMI.2016.2544958 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using Bayesian regularization: validation and application to brain imaging. Magn Reson Med. 2010;63(1):194–206. doi: 10.1002/mrm.22187 [DOI] [PubMed] [Google Scholar]
- 160.Langkammer C, Bredies K, Poser BA, et al. Fast quantitative susceptibility mapping using 3D EPI and total generalized variation. NeuroImage. 2015;111(February 2016):622–630. doi: 10.1016/j.neuroimage.2015.02.041 [DOI] [PubMed] [Google Scholar]
- 161.Milovic C, Bilgic B, Zhao B, Acosta-Cabronero J, Tejos C. Fast nonlinear susceptibility inversion with variational regularization. Magn Reson Med. 2018;80(2):814–821. doi: 10.1002/mrm.27073 [DOI] [PubMed] [Google Scholar]
- 162.Schweser F, Sommer K, Deistung A, Reichenbach JR. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. NeuroImage. 2012;62(3):2083–2100. doi: 10.1016/j.neuroimage.2012.05.067 [DOI] [PubMed] [Google Scholar]
- 163.Liu J, Liu T, de Rochefort L, et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. NeuroImage. 2012;59(3):2560–2568. doi: 10.1016/j.neuroimage.2011.08.082 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Milovic C, Prieto C, Bilgic B, et al. Comparison of parameter optimization methods for quantitative susceptibility mapping. Magn Reson Med. August 2020:mrm.28435. doi: 10.1002/mrm.28435 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Botnar RM, Stuber M, Danias PG, Kissinger KV, Manning WJ. Improved Coronary Artery Definition With T2-Weighted, Free-Breathing, Three-Dimensional Coronary MRA. Circulation. 1999;99(24):3139–3148. doi: 10.1161/01.CIR.99.24.3139 [DOI] [PubMed] [Google Scholar]
- 166.Bilgic B, Chatnuntawech I, Fan AP, et al. Fast image reconstruction with L2-regularization. J Magn Reson Imaging. 2014;40(1):181–191. doi: 10.1002/jmri.24365 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Kressler B, de Rochefort L, Spincemaille P, Liu T, Wang Y. Estimation of Sparse Magnetic Susceptibility Distributions from MRI using Non-linear Regularization. In: Proc Intl Soc Mag Reson Med 16 (2008). Toronto; 2008:1514. [Google Scholar]
- 168.Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. NeuroImage. 2011;55(4):1645–1656. doi: 10.1016/j.neuroimage.2010.11.088 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Schweser F, Deistung A, Sommer K, Reichenbach JR. Toward online reconstruction of quantitative susceptibility maps: Superfast dipole inversion. Magn Reson Med. 2013;69(6):1581–1593. doi: 10.1002/mrm.24405 [DOI] [PubMed] [Google Scholar]
- 170.Wang S, Liu T, Chen W, et al. Noise Effects in Various Quantitative Susceptibility Mapping Methods. IEEE Trans Biomed Eng. 2013;60(12):3441–3448. doi: 10.1109/TBME.2013.2266795 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Wei H, Dibb R, Zhou Y, et al. Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range. NMR Biomed. 2015;28(10):1294–1303. doi: 10.1002/nbm.3383 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Chen Y, Liu S, Kang Y, Haacke EM. A rapid, robust multi-echo phase unwrapping method for quantitative susceptibility mapping (QSM) using strategically acquired gradient echo (STAGE) data acquisition. In: Chen GH, Lo JY, Gilat Schmidt T, eds. Medical Imaging 2018: Physics of Medical Imaging. Houston, United States: SPIE; 2018:101. doi: 10.1117/12.2292951 [DOI] [Google Scholar]
- 173.Gharabaghi S, Liu S, Wang Y, et al. Multi-Echo Quantitative Susceptibility Mapping for Strategically Acquired Gradient Echo (STAGE) Imaging. Front Neurosci. 2020;14:581474. doi: 10.3389/fnins.2020.581474 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Liu T, Liu J, de Rochefort L, et al. Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: Comparison with COSMOS in human brain imaging. Magn Reson Med. 2011;66(3):777–783. doi: 10.1002/mrm.22816 [DOI] [PubMed] [Google Scholar]
- 175.Li W, Wang N, Yu F, et al. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping. NeuroImage. 2014;108:111–122. doi: 10.1016/j.neuroimage.2014.12.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Dimov AV, Nguyen TD, Spincemaille P, et al. Global cerebrospinal fluid as a zero-reference regularization for brain quantitative susceptibility mapping. J Neuroimaging. 2022;32(1):141–147. doi: 10.1111/jon.12923 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Bollmann S, Rasmussen KGB, Kristensen M, et al. DeepQSM - using deep learning to solve the dipole inversion for quantitative susceptibility mapping. NeuroImage. 2019;195:373–383. doi: 10.1016/j.neuroimage.2019.03.060 [DOI] [PubMed] [Google Scholar]
- 178.Yoon J, Gong E, Chatnuntawech I, et al. Quantitative susceptibility mapping using deep neural network: QSMnet. NeuroImage. 2018;179:199–206. doi: 10.1016/j.neuroimage.2018.06.030 [DOI] [PubMed] [Google Scholar]
- 179.De A, Sun H, Emery DJ, Butcher KS, Wilman AH. Quantitative susceptibility-weighted imaging in presence of strong susceptibility sources: Application to hemorrhage. Magn Reson Imaging. 2022;92:224–231. doi: 10.1016/j.mri.2022.06.010 [DOI] [PubMed] [Google Scholar]
- 180.Hagberg GE, Eckstein K, Tuzzi E, Zhou J, Robinson S, Scheffler K. Phase-based masking for quantitative susceptibility mapping of the human brain at 9.4T. Magn Reson Med. 2022;88(5):2267–2276. doi: 10.1002/mrm.29368 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 181.Liu Z, Kee Y, Zhou D, Wang Y, Spincemaille P. Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping. Magn Reson Med. 2016;00(January). doi: 10.1002/mrm.26331 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Wen Y, Spincemaille P, Nguyen T, et al. Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping. Magn Reson Med. 2021;86(4):2165–2178. doi: 10.1002/mrm.28814 [DOI] [PubMed] [Google Scholar]
- 183.Milovic C, Lambert M, Langkammer C, Bredies K, Irarrazaval P, Tejos C. Streaking artifact suppression of quantitative susceptibility mapping reconstructions via L1-norm data fidelity optimization (L1-QSM). Magn Reson Med. 2022;87(1):457–473. doi: 10.1002/mrm.28957 [DOI] [PubMed] [Google Scholar]
- 184.Bao C, Choi JK, Dong B. Whole Brain Susceptibility Mapping Using Harmonic Incompatibility Removal. ArXiv180512521 Cs Math. May 2018. http://arxiv.org/abs/1805.12521. Accessed January 2, 2019. [Google Scholar]
- 185.Balasubramanian PS, Spincemaille P, Guo L, Huang W, Kovanlikaya I, Wang Y. Spatially Adaptive Regularization in Total Field Inversion for Quantitative Susceptibility Mapping. iScience. 2020;23(10):101553. doi: 10.1016/j.isci.2020.101553 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Haacke EM, Tang J, Neelavalli J. Susceptibility Mapping as a Means to Visualize Veins and Quantify Oxygen Saturation. J Magn Reson Imaging. 2010;676:663–676. doi: 10.1002/jmri.22276 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.Tang J, Liu S, Neelavalli J, Cheng YCN, Buch S, Haacke EM. Improving susceptibility mapping using a threshold-based K-space/image domain iterative reconstruction approach. Magn Reson Med. 2013;69(5):1396–1407. doi: 10.1002/mrm.24384 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188.Buch S, Liu S, Ye Y, Cheng YCN, Neelavalli J, Haacke EM. Susceptibility mapping of air, bone, and calcium in the head. Magn Reson Med. 2015;73(6):2185–2194. doi: 10.1002/mrm.25350 [DOI] [PubMed] [Google Scholar]
- 189.Polak D, Chatnuntawech I, Yoon J, et al. Nonlinear dipole inversion (NDI) enables robust quantitative susceptibility mapping (QSM). NMR Biomed. 2020;33(12):e4271. doi: 10.1002/nbm.4271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Zachariou V, Bauer CE, Powell DK, Gold BT. Ironsmith: An Automated Pipeline for QSM-based Data Analyses. NeuroImage. December 2021:118835. doi: 10.1016/j.neuroimage.2021.118835 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Lancione M, Tosetti M, Donatelli G, Cosottini M, Costagli M. The impact of white matter fiber orientation in single-acquisition quantitative susceptibility mapping. NMR Biomed. 2017;(August):1–8. doi: 10.1002/nbm.3798 [DOI] [PubMed] [Google Scholar]
- 192.Lee J, Shmueli K, Fukunaga M, et al. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc Natl Acad Sci U A. 2010;107(11):5130–5135. doi: 10.1073/pnas.0910222107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 193.Li W, Liu C, Duong TQ, van Zijl PCM, Li X. Susceptibility tensor imaging (STI) of the brain: Review of susceptibility tensor imaging of the brain. NMR Biomed. 2017;30(4):e3540. doi: 10.1002/nbm.3540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 194.Wharton S, Bowtell R. Fiber orientation-dependent white matter contrast in gradient echo MRI. Proc Natl Acad Sci. 2012;109(45):18559–18564. doi: 10.1073/pnas.1211075109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 195.Wharton SJ, Bowtell R. Effects of white matter microstructure on phase and susceptibility maps. Magn Reson Med. 2015;73(3):1258–1269. doi: 10.1002/mrm.25189 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196.Schweser F, Raffaini Duarte Martins AL, Hagemeier J, et al. Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality. NeuroImage. 2018;167:438–452. doi: 10.1016/j.neuroimage.2017.10.063 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197.Singh MK, Singh KK. A Review of Publicly Available Automatic Brain Segmentation Methodologies, Machine Learning Models, Recent Advancements, and Their Comparison. Ann Neurosci. 2021;28(1–2):82–93. doi: 10.1177/0972753121990175 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 198.Derakhshan M, Caramanos Z, Giacomini PS, et al. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. NeuroImage. 2010;52(4):1261–1267. doi: 10.1016/j.neuroimage.2010.05.029 [DOI] [PubMed] [Google Scholar]
- 199.Gelman N, Ewing JR, Gorell JM, Spickler EM, Solomon EG. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn Reson Med. 2001;45(1):71–79. [DOI] [PubMed] [Google Scholar]
- 200.Vrenken H, Geurts JJG, Knol DL, et al. Whole-Brain T1 Mapping in Multiple Sclerosis: Global Changes of Normal-appearing Gray and White Matter. Radiology. 2006;240(3):811–820. doi: 10.1148/radiol.2403050569 [DOI] [PubMed] [Google Scholar]
- 201.Ide S, Kakeda S, Ueda I, et al. Internal structures of the globus pallidus in patients with Parkinson’s disease: evaluation with quantitative susceptibility mapping (QSM). Eur Radiol. November 2014. doi: 10.1007/s00330-014-3472-7 [DOI] [PubMed] [Google Scholar]
- 202.Li X, Chen L, Kutten K, et al. Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility. NeuroImage. 2019;191:337–349. doi: 10.1016/j.neuroimage.2019.02.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203.Probst J, Rohner M, Zahn M, et al. Quantitative susceptibility mapping in ischemic stroke patients after successful recanalization. Sci Rep. 2021;11(1):16038. doi: 10.1038/s41598-021-95265-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204.Ward PGD, Fan AP, Raniga P, et al. Improved Quantification of Cerebral Vein Oxygenation Using Partial Volume Correction. Front Neurosci. 2017;11. https://www.frontiersin.org/articles/10.3389/fnins.2017.00089. Accessed February 7, 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 205.Borland D, Taylor II RM. Rainbow Color Map (Still) Considered Harmful. IEEE Comput Graph Appl. 2007;27(2):14–17. doi: 10.1109/MCG.2007.323435 [DOI] [PubMed] [Google Scholar]
- 206.Crameri F, Shephard GE, Heron PJ. The misuse of colour in science communication. Nat Commun. 2020;11(1):5444. doi: 10.1038/s41467-020-19160-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 207.Griswold MA, Sunshine JL, Seiberlich N, Gulani V. Towards Unified Colormaps for Quantitative MRF Data. In: Proc Intl Soc Mag Reson Med 26 (2018).; 2018:p2894. [Google Scholar]
- 208.Kiselev VG. Larmor Frequency in Heterogeneous Media. J Magn Reson. 2019;299:168–175. [DOI] [PubMed] [Google Scholar]
- 209.Sandgaard AD, Shemesh N, Kiselev VG, Jespersen SN. Larmor frequency shift from magnetized cylinders with arbitrary orientation distribution. NMR Biomed. 2023. doi: 10.1002/nbm.4859 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 210.Sati P, van Gelderen P, Silva AC, et al. Micro-compartment specific T2* relaxation in the brain. NeuroImage. 2013;77:268–278. doi: 10.1016/j.neuroimage.2013.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 211.Lancione M, Donatelli G, Cecchi P, Cosottini M, Tosetti M, Costagli M. Echo-time dependency of quantitative susceptibility mapping reproducibility at different magnetic field strengths. NeuroImage. 2019;197:557–564. doi: 10.1016/j.neuroimage.2019.05.004 [DOI] [PubMed] [Google Scholar]
- 212.Sood S, Urriola J, Reutens D, et al. Echo time-dependent quantitative susceptibility mapping contains information on tissue properties: Temporal Quantitative Susceptibility Mapping. Magn Reson Med. 2017;77(5):1946–1958. doi: 10.1002/mrm.26281 [DOI] [PubMed] [Google Scholar]
- 213.Khabipova D, Wiaux Y, Gruetter R, Marques JP. A Modulated Closed Form solution for Quantitative Susceptibility Mapping - A thorough evaluation and comparison to iterative methods based on edge prior knowledge. NeuroImage. 2014;107:163–174. doi: 10.1016/j.neuroimage.2014.11.038 [DOI] [PubMed] [Google Scholar]
- 214.Wharton SJ, Bowtell RW. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. NeuroImage. 2010;53(2):515–525. doi: 10.1016/j.neuroimage.2010.06.070 [DOI] [PubMed] [Google Scholar]
- 215.Dimov AV, Gupta A, Kopell BH, Wang Y. High-resolution QSM for functional and structural depiction of subthalamic nuclei in DBS presurgical mapping. J Neurosurg. 2019;131(2):360–367. doi: 10.3171/2018.3.JNS172145 [DOI] [PubMed] [Google Scholar]
- 216.Al-Radaideh AM, Athamneh I, Alabadi H, Hbahbih M. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load. Clin Neuroradiol. 2018. doi: 10.1007/s00062-017-0654-0 [DOI] [PubMed] [Google Scholar]
- 217.Chen W, Zhang Y, Mu K, et al. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping. Am J Roentgenol. 2017;(October):1–6. doi: 10.2214/AJR.16.16851 [DOI] [PubMed] [Google Scholar]
- 218.Kaunzner UW, Kang Y, Zhang S, et al. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain. 2019;142(1):133–145. doi: 10.1093/brain/awy296 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 219.Lim IAL, Faria AV, Li X, et al. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: Application to determine iron content in deep gray matter structures. NeuroImage. 2013;82:449–469. doi: 10.1016/j.neuroimage.2013.05.127 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 220.Pontillo G, Petracca M, Monti S, et al. Unraveling Deep Gray Matter Atrophy and Iron and Myelin Changes in Multiple Sclerosis. Am J Neuroradiol. April 2021:ajnr;ajnr.A7093v1. doi: 10.3174/ajnr.A7093 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 221.Yu FF, Chiang FL, Stephens N, et al. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging. Neuroradiology. 2019;61(1):71–79. doi: 10.1007/s00234-018-2137-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 222.Lotfipour AK, Wharton SJ, Schwarz ST, et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson’s disease. J Magn Reson Imaging. 2012;35(1):48–55. doi: 10.1002/jmri.22752 [DOI] [PubMed] [Google Scholar]
- 223.Reichenbach JR, Schweser F, Serres B, Deistung A. Quantitative Susceptibility Mapping: Concepts and Applications. Clin Neuroradiol. 2015;25(S2):225–230. doi: 10.1007/s00062-015-0432-9 [DOI] [PubMed] [Google Scholar]
- 224.Al-Radaideh AM, Wharton SJ, Lim SY, et al. Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome. Mult Scler. 2013;19(7):896–903. doi: 10.1177/1352458512465135 [DOI] [PubMed] [Google Scholar]
- 225.Cobzas D, Sun H, Walsh AJ, Lebel RM, Blevins G, Wilman AH. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis. J Magn Reson Imaging. 2015;42(6):1601–1610. doi: 10.1002/jmri.24951 [DOI] [PubMed] [Google Scholar]
- 226.Feng X, Deistung A, Reichenbach JR. Quantitative susceptibility mapping (QSM) and R2* in the human brain at 3 T. Z Med Phys. 2018;28(1):36–48. doi: 10.1016/j.zemedi.2017.05.003 [DOI] [PubMed] [Google Scholar]
- 227.Zivadinov R, Tavazzi E, Bergsland N, et al. Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis. Radiology. 2018;289(2):487–496. doi: 10.1148/radiol.2018180136 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.









